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Poly(lactic acid) or polylactide (PLA) is the most extensively
researched and utilized biodegradable and renewable aliphatic polyes-
ter. PLA has a proven potential either to replace conventional
petrochemical-based polymers for industrial applications or as a leading
biomaterial for numerous applications in medicine [1,2].
Environmental, economic, and safety challenges have provoked pack-
aging scientists and producers to partially substitute petrochemical-
based polymers with biodegradable ones [3]. PLA as a leading candidate,
is a thermoplastic, high-strength, high-modulus polymer that can be
made from annually renewable resources to yield different components
for use in either the industrial packaging ﬁeld or the biocompatible/
bioabsorbablemedical devicemarket. It is easily processable on standard
plastic equipment to yield molded parts, ﬁlm, or ﬁbers [4,5].
As a bioabsorbable polymer, PLA, is one of the most promising bio-
polymers due to the fact that the monomers may be produced from
non-toxic renewable feedstock as well as due to being a naturally occur-
ring organic acid [6,7]. Lactic acid (2-hydroxypropionic acid, LA), a PLA
constituent unit, since it is a chiral molecule, exists as two enantiomers,
L- and D-lactic acid (Fig. 1), PLA has stereoisomers, such as poly(L-lactide)
(PLLA), poly(D-lactide) (PDLA), and poly(DL-lactide) (PDLLA) [1]. Lactic
acid can bemade by fermentation of sugars obtained from renewable re-
sources as such sugarcane or corn starch [4]. Therefore, PLA is an eco-
friendly product with better features for use in the human body
(nontoxicity). PLA is the ﬁrst commodity polymer produced from annu-
ally renewable resources [8]. It is classiﬁed as generally recognized as
safe (GRAS) by the United State Food and Drug Administration (FDA)
and is safe for all food packaging applications [3,9]. The research on lactic
acid based polymers intended for medical applications has accelerated
since FDA approval, and during the last two decades an increasing utili-
zation of large scale industrial lactic acid based polymers for other uses
has occurred [10–12].
PLA was synthesized in 1932 by Carothers (at DuPont). He was only
able to produce a lowmolecular weight (Mw) PLA by heating lactic acid
under vacuum while removing the condensed water. The problem at
that time was to increase the Mw of the products; and, ﬁnally, by
ring-opening polymerization of the lactide, high-Mw PLA was synthe-
sized (Fig. 2) [3,7]. Today, although there are multiple ways to fabricate
PLA, none of them is simple or easy to execute. PLA synthesis requires
rigorous control of conditions (temperature, pressure and pH), the use
of catalysts and long polymerization times [6,7]. PLA can be prepared
by different polymerization processes from lactic acid including: poly-
condensation, ring opening polymerization and by direct methods like
azeotopic dehydration and enzymatic polymerization [5]. Currently,Fig. 1. Atomic chemical structure of L- and D-lactic acid.
(Reprinted from [6]).
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comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10direct polymerization and ring opening polymerization are the most
used production techniques. Fig. 2 shows the main methods for PLA
synthesis.
In comparison to other biopolymers, the production of PLA has nu-
merous advantages [3], including: 1) Eco-friendly — apart from being
derived from renewable resources (e.g., corn, wheat, or rice), PLA is bio-
degradable, recyclable, and compostable [2,13]. Its production also con-
sumes carbon dioxide [14]. 2) Biocompatibility — the most attractive
aspect of PLA, especially with respect to biomedical applications. A bio-
compatible material should not produce toxic or carcinogenic effects in
local tissues. Also, the degradation products should not interfere with
tissue healing. PLA hydrolyzes to its constituent α-hydroxy acid when
implanted in living organisms, including the human body. It is then in-
corporated into the tricarboxylic acid cycle and excreted. Moreover, PLA
degradation products are non-toxic (at a lower composition) making it
a natural choice for biomedical applications [15]. The FDA has also
approved PLA for direct contacting with biological ﬂuids [16]. 3) -
Processibility — PLA has better thermal processibility compared
to other biopolymers such as poly(hydroxyl alkanoate) (PHA),
poly(ethylene glycol) (PEG) and poly(γ-caprolactone) (PCL). It can be
processed by injection molding, ﬁlm extrusion, blow molding,
thermoforming, ﬁber spinning, and ﬁlm forming [17]. 4) Energy
savings — PLA requires 25–55% less energy to produce than
petroleum-based polymers and estimations show that this can be fur-
ther reduced to less than 10% in the future [15]. Lower energy use
makes PLA production potentially advantageous with respect to cost
as well. Although, despite the above positive features, PLA has draw-
backs as well, which limit its use in certain applications, mainly:
1) Poor toughness — PLA is a very brittle material with less than 10%
elongation at break [19]. Although its tensile strength and elastic mod-
ulus are comparable to poly(ethylene terephthalate) (PET) [17,18], the
poor toughness limits its use in the applications that need plastic defor-
mation at higher stress levels (e.g., screws and fracture ﬁxation plates)
[15]. 2) Slow degradation rate — PLA degrades through the hydrolysis
of backbone ester groups and the degradation rate depends on the
PLA crystallinity, Mw and its distribution, morphology, water diffusion
rate into the polymer, and the stereoisomeric content [20]. The degrada-
tion rate is often considered to be an important selection criterion for
biomedical applications [21]. The slow degradation rate leads to a long
in vivo life time, which could be up to years in some cases (mostly 3–
5 years) [15]. The slowdegradation rate is a serious problemwith respect
to disposal of consumer commodities aswell. 3)Hydrophobicity— PLA is
relatively hydrophobic, with a staticwater contact angle of approximate-
ly 80 °C. This results in low cell afﬁnity, and can elicit, in some cases, an
inﬂammatory response from the living host upon direct contact with bi-
ological ﬂuids [22]. 4) Lack of reactive side-chain groups— PLA is chem-
ically inert with no reactive side-chain groups making its surface and
bulk modiﬁcations a challenging task.
In recent times, several PLA-based technologies have emerged with
an emphasis on achieving chemical,mechanical, andbiological properties
equivalent or superior to conventional polymers. The frequent need for a
chemical or physical modiﬁcation of PLA to achieve suitable properties
for its intended consumer and biomedical applications, has demanded
signiﬁcant attention in the last decade. The successful implementation
of PLA in consumer and biomedical applications relies not only on me-
chanical properties being better than or comparable to conventional plas-
tics, but also on controlled surface properties (e.g., hydrophilicity,
roughness, and reactive functionalities). PLA has been bulk modiﬁedperties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
Fig. 2. Synthesis methods for poly(lactic acid).
(Adapted from [1,5,7]).
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cation has been attempted to control hydrophilicity, roughness, and to in-
troduce reactive groups. Toughness improvement is a crucial necessity
formany consumer applications,while the improvements in hydrophilic-
ity and introduction of reactive groups are beneﬁcial for biomedical appli-
cations. Improvements in degradation rate could also be important in
both consumer and biomedical applications [15].
Several reviews have been written which include details on the
properties and characteristics of PLA [8,12,23]. Here in this work, our
focus is on elaborating the mechanical and physical properties that af-
fect PLA's stability, processability, degradation, PLA-other polymers im-
miscibility, aging and recyclability, and therefore its potential suitability
to fulﬁll speciﬁc application requirements. PLA's property variations
during PLA processing, biodegradation, packaging and sterilization,
and aging were studied and summarized. In the second part of the re-
view we discuss up-to-date strategies for PLA property improvements
including components and plasticizer blending, nucleation agent addi-
tion, and PLA modiﬁcations and nanoformulations. These aspects rarely
have been found discussed together. Several examples on PLA property
functions in widespread applications are also given in the last part. The
main review goal is combining better understanding of the role of these
properties with available improvement strategies for successful utiliza-
tion of PLA and its copolymers/composites/blends to maximize their
applications.
2. Properties of lactic acid-based polymers
PLA's properties have been the subject of extensive research [1,6,24].
Here, in this section, is a brief overview on the main studied PLA prop-
erties, followed by deep consideration of PLA's physical and mechanical
properties in the following sections.
Properties of PLAdependon its component isomers, processing tem-
perature, annealing time and Mw [6,24,25]. The stereochemistry and
thermal history have direct inﬂuence on PLA crystallinity, and therefore,
on its properties in general. A very important property of polymers is
the rate of crystallinity where crystallinity is the indication of amount
of crystalline region in the polymer with respect to amorphous content.
Crystallinity inﬂuences many polymer properties including hardness,
modulus, tensile strength, stiffness, crease and melting points. So,Please cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10while selecting a polymer for a required application, its crystallinity
plays the foremost role [3].
PLA crystals can grow in 3 structural positions called α, β, and γ
forms. They are characterized by different helix conformations and
cell symmetries, which develop upon different thermal and/or
mechanical treatments [1]. The α form grows upon melt or cold crys-
tallization, the β form develops upon mechanical stretching of the
more stable α form, and the γ form, which recently has been report-
ed to develop on hexamethylbenzene substrate [26]. PLA properties
may be controlled through the use of special catalysts of isotactic
and syndiotactic content with different enantiometric units [16].
PLA with PLLA content higher than 90% tends to be crystalline,
while the lower optically pure is amorphous. The melting tempera-
ture (Tm), and the glass transition temperature (Tg) of PLA decrease
with decreasing amounts of PLLA [7].
Physical characteristics such as density, heat capacity, and mechani-
cal and rheological properties of PLA are dependent on its Tg [8]. For
amorphous PLA, the Tg is one of the most important parameters since
dramatic changes in polymer chain mobility take place at and above
Tg. For semicrystalline PLA, both Tg and Tm are important physical pa-
rameters for predicting PLA behavior [17,27,28]. Themelt enthalpy esti-
mated for an enantiopure PLA of 100% crystallinity (ΔH°m) is 93 J/g; it is
the value most often referred to in the literature although higher values
(up to 148 J/g) also have been reported. The Tm and degree of crystallin-
ity are depended on the molar mass, thermal history and purity of the
polymer [29]. The density of amorphous and crystalline PLLA has been
reported as 1.248 g/ml and 1.290 g/ml, respectively. The density of
solid PLA was reported as 1.36 g/cm3 for L-lactide, 1.33 g/cm3 for
meso-lactide, 1.36 g/cm3 and 1.25 g/cm3 for crystalline and amorphous
PLA, respectively [17].
PLA solubility— in general, PLA products are soluble in dioxane, ace-
tonitrile, chloroform, methylene chloride, 1,1,2-trichloroethane and
dichloroacetic acid. Ethyl benzene, toluene, acetone and tetrahydrofu-
ran only partly dissolve PLAswhen cold, though they are readily soluble
in these solvents when heated to boiling temperatures. Lactic acid-
based polymers are not soluble inwater, alcohols such asmethanol, eth-
anol and propylene glycol and unsubstituted hydrocarbons (e.g. hexane
and heptane). Crystalline PLLA is not soluble in acetone, ethyl acetate or
tetrahydrofuran [6,10].perties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
Fig. 3. Barrier properties of PLA in comparison to other common polymers, Low-density
polyethylene (LDPE), polyethylene terephthalate (PET) and polystyrene (PS) at 30 °C
(a) N2, (b) O2, (c) CO2, and (d) CH4.
Data collected from [38,43,44].
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sure to moisture. PLA degradation occurs in two stages. First, random
non-enzymatic chain scission of the ester groups leads to a reduction
in Mw. In the second stage, the Mw is reduced until the lactic acid and
low Mw oligomers are naturally metabolized by microorganisms to
yield carbon dioxide and water [17,30]. The polymer degradation rate
is mainly determined by polymer reactivity with water and catalysts.
Any factor which affects the reactivity and the accessibility, such as par-
ticle size and shape, temperature, moisture, crystallinity, % isomer, re-
sidual lactic acid concentration, Mw, water diffusion and metal
impurities from the catalyst, will affect the polymer degradation rate
[2,17,31–33]. The in vivo and in vitro degradation have been evaluated
for PLA surgical implants. In vitro studies showed that the pH of the
solution does play a role in the in vitro degradation, and that, an
in vivo study can be used as a predictor of the in vivo degradation of
PLA [17,34].
The Mw has a signiﬁcant impact on the properties of polymers such
as degradation, mechanical strength and solubility. High Mw PLA has a
complete resorption time of 2 to 8 years. This prolonged existence
in vivo in some organs may lead to inﬂammation and infection [35].
Therefore, production of lowMwPLA is desirable as it provides a shorter
degradation rate. Mainil-Varlet studied the degradation rate of lowMw
PLLA (60,000 g/mol) and found that the implants were able tomaintain
mechanical properties for a period of time usually required for bone
fracture healing. Low Mw PLAs that are used for drug delivery have a
weak retarding effect. They degrade by hydrolysis relatively fast into
lactic acid, which reduces the risk of material accumulation in tissue
[34]. For example, PLA with Mw between 2000 and 20,000 g/mol was
used by Andreopoulos as an implantable antibiotic release system.
They found that the sustained release of antibiotics in low and high
Mw implants lasted 33 days and more than 3 months, respectively
[36]. Jabbari and He, developed an injectable and bioresorbable
macromer using PLLA (number-average molecular weight (Mn)
1200 g/mol) as a starting material. It is reported that an injectable hy-
drogel can be prepared by the addition of acrylate or fumarate units to
lowMwPLLA. This particular functionalized PLA has a favorable biodeg-
radation rate [37].
Bymodiﬁcation of the chain architecture through the introduction of
branching, different melt ﬂow properties will be obtained [1]. Thermal
and rheological properties of 2 commercial types of PLA, linear and
branched, were investigated by Dorgan and others [38]. The crystalliza-
tion kinetic of the branched polymer was faster than that of the linear
analog. Longer relaxation times in the terminal region of the branched
material introduced it as a higher zero shear rate viscosity. They con-
cluded that by utilizing the structure modiﬁcations through polymer
branching the ability of using PLA in many processing operations will
be extended.
PLA stereocomplexes can be produced by enantiomers with identi-
cal chemical composition but with different steric structures. Since
preparation in 1987, the stereocomplex between PLLA and PDLA has
been intensively studied by utilizing different preparations, structures
and functional properties, enhanced characteristics have been reported
especially for drug delivery applications [39].
PLA can also be tailored by formulation involving co-polymerization
of the lactide with other lactone-type monomers, hydrophilic
macromonomers (PEG), other monomers with functional groups
(such as amino and carboxylic groups), or blending PLA with other ma-
terials [6,40]. Blending can radically alter the resultant properties,which
depend sensitively on the mechanical properties of the components as
well as the blend microstructure and the interface between the phases
[41]. Broz prepared a series of blends of the biodegradable polymers
PDLLA and PCL by varying mass fraction across the range of composi-
tions. Itwas found that polymersmade from ε-caprolactonewere excel-
lent drug permeation products [41].
Optical properties of PLA are important in dyeing operations for tex-
tiles and in various packaging applications where clarity is desirable.Please cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10Hutchinson and others determined the optical properties of PLA with
different amounts of stereoisomer proportions by ellipsometric mea-
surements. They developed an equation for index of refraction of PLA
with a wide range of stereoisomer proportions (L-content) within the
range ofwavelengths from 300 to 1300 nmby using Cauchy coefﬁcients
[42].
PLA barrier properties — one of the most important factors in food
packagingpolymers is their barrier or permeability performance against
transfer of gases, water vapor, and aroma molecules. Gas permeation
properties of PLA (L:D ratio 96:4) have been studied by Lehermeier
and others [38,43,44] and these values are summarized in Fig. 3. The au-
thors concluded that polymer chain branching and small changes in L:D
stereochemical content have no effect on permeation properties, but
ﬁlm crystallinity profoundly impacted the permeation of thementioned
gases. For example, due to higher crystallinity of biaxially oriented PLA
ﬁlm, CH4 permeation is 4.5 times lower than that of the other ﬁlms. In
an earlier study by Shogren the water vapor transmission rate
(WVTR) of crystalline and amorphous PLA in 6, 25, and 49 °C was re-
ported as 27, 82, and 333 g/m2 per day for the crystalline form and 54,
172, and 1100 g/m2 per day for the amorphous form, respectively
[45]. He reported activation energies of 5 and−0.1 kJ/mol for amor-
phous and crystalline PLA, respectively [45]. In a more detailed study
by Tsuji and others [46], the effects of D-lactide content, degree of crys-
tallinity, andMwof PLAﬁlms onWVTRwere studied. They observed the
WVTR of PLA ﬁlms decreased monotonically with increasing crystallin-
ity from 0% to 20%, while leveled off for crystallinity exceeding 30%; so
they suggested this change due to the higher resistance of restricted
amorphous regions to water vapor permeation compared with that of
the free amorphous regions. They also concluded that changes in Mn
of PLA ﬁlms in the range of 9 × 104 to 5 × 105 g/mol and D-lactide unit
content of PLA ﬁlms in the range of 0% to 50% have insigniﬁcant effects
on theirWVTR values [3,46]. In a study by Auras and others [47], orient-
ed PLA (OPLA) was investigated with PET and oriented polystyrene
(OPS) with regard to physical, mechanical, and barrier properties.
They concluded, in terms of water vapor barrier, that PET gave the
best performance, followed by OPS and OPLA. In the case of oxygen bar-
rier properties, PET showed the lowest oxygen permeability coefﬁ-
cients, followed by OPLA and OPS that showed very poor oxygen
barrier performance. According to these results, the barrier properties
of PLA are remarkable and better than those of OPS. As a consequence,
PLA is suitable for packaging a wide range of food applications [3,47].
A very important property is the water content or water uptake of the
biopolymer resin. PLA resins were tested and they were found to be sit-
uated near 0.5% [48].
Fragmented data on several other useful properties could be found:
crimp [49], melt ﬂow indices [49–52,58], impact properties [49,53,54],
hardness [48], vapor transmission characteristics (mainly for ﬁlmperties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
5S. Farah et al. / Advanced Drug Delivery Reviews xxx (2016) xxx–xxxapplications) [55–58], compostabilities [51,52,55–58], coefﬁcients of
friction [58], surface energies and contact angles with water [58,59].
Since data on these and other properties were so fragmentary, they
were nearly impossible to evaluate.
There are many PLA resins for different applications with varied
properties; the general characteristics of thewidely-leading commercial
amorphous PLA produced by NatureWorks Co., prepared by injection
mold and having a 96:4 L:D ratio content, are summarized in Table 1.
2.1. Physical properties
Physical properties are important; one must know the dimensions,
size, and weight requirements for a desired part or product. For exam-
ple, if used by a surgeon, it must be light enough to handle precisely
as implementation of material also becomes much easier and less haz-
ardouswhen lighter [4]. Density can also be a very important design pa-
rameter since elevated density values imply high transportation costsTable 1
General characteristics of a commercial amorphous PLA, injection mold grade (96:4 L:D
ratio content produced by NatureWorks Co. [3]).
Characteristics Unit Amount Reference
Physical:
Mw g/mol 66,000 [5]
Speciﬁc gravity – 1.27
Solid density g/cm3 1.252
Melt density g/cm3 1.073
Tg °C 55 [60]
Tm °C 165
Speciﬁc heat (Cp) J/kg °C
190 °C 2060
100 °C 1955
55 °C 1590
Thermal conductivity W/m °C
190 °C 0.195 [61]
109 °C 0.197
48 °C 0.111
Optical:
UV light transmission [17]
190 to 220 nm b5%
225 to 250 nm 85%
N300 nm 95%
Visible light transmission 95%
Color
L∗ 90.64 ± 0.21
a∗ −0.99 ± 0.01
b∗ −0.50 ± 0.04
Mechanical:
Tensile strength Mpa 59
Elongation at break % 7
Elastic modulus MPa 3500
Shear modulus MPa 1287
Poisson's ratio – 0.36 [61]
Yield strength MPa 70
Flexural strength MPa 106
Unnotched izod J/m 195
Notch izod impact J/m 26
Rockwell hardness HR 88
Heat deﬂection temp °C 55
Vicat penetration °C 59
Ultimate tensile strength MPa 73
Percent of elongation % 11.3
Young's modulus MPa 1280
Rheological:
Cross WLF viscosity model:
n 0.25
Tau Pa 1.00861 ∗ 105 [61]
D1 Pa-s 3.31719 ∗ 109
D2 K 373
D3 K/P 0
A1 20.2
A2 K 51.6
Please cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10(e.g. light car parts reduce energy consumption). Density is often used
for the calculation of ‘speciﬁc properties’, i.e. dividing mechanical prop-
erties by the appropriate density. These speciﬁc properties consequent-
ly give a better notion of the intrinsic strength of the construct one
wants to build [48]. The density of PLA in comparison to a series of bio-
polymers is given in Table 2.
Polymers may be either semicrystalline or amorphous. Semicrystal-
line polymers have regular repeating units that allow the chains to fold
into dense regions called crystallites. These act as crosslinks giving the
polymer higher tensile strengths and higher modulus (stiffness) as
compared to an amorphous analog. No polymer can completely orga-
nize into a fully crystalline material so there are still amorphous areas
in semicrystalline polymers [62]. Characteristic temperatures of a poly-
mer can be determined in several ways, but DSC (differential scanning
calorimetry) is the most cited one. The ﬂexibility of amorphous poly-
mers is reduced drastically when they are cooled below a characteristic
transition temperature called the Tg. At temperatures below Tg, there is
no segmental motion and any dimensional changes in the polymer are
the result of temporary distortions of the primary valence bonds. Amor-
phous plastics, such as all the D,L-PLA containing ones perform best
below Tg, but elastomers must be used above the brittle point [63].
The Tg can be very important when studying mechanical properties
(Table 2). These properties are always obtained in standard conditions
(comparable to room temperature), but one should know that they
may decrease at higher temperatures and that the Tg may be a limit
above which mechanical properties may degrade drastically [48].
The Tm is a more important parameter. Above it, whole polymer
chain mobility occurs and the mechanical properties are virtually re-
duced to zero. Together with the melt points one should also look at
the process temperatures. These are by deﬁnition signiﬁcantly higher
than the melt points because at these higher temperatures viscosity is
reduced drastically in order to improve processability. These tempera-
tures for PLA are ranging from 190 to 250 °C [49,51,52,55–58].
In the solid state, PLA can be either amorphous or semicrystalline, de-
pending on the stereochemistry and thermal history. For amorphous
PLAs, the Tg determines the upper use temperature for most commercial
applications. For semicrystalline PLAs, both the Tg (~58 °C) and Tm, (130–
230 °C, depending on structure) are important for determining the use
temperatures across various applications. Both of these transitions, Tg
and Tm, are strongly affected by overall optical composition, primary struc-
ture, thermal history, and Mw. Above Tg amorphous PLAs transition from
glassy to rubbery and will behave as a viscous ﬂuid upon further heating.
Below Tg, PLA behaves as a glass with the ability to creep until cooled to
its β-transition temperature of approximately−45 °C. Below this temper-
ature PLA will only behave as a brittle polymer [8].
Polymers prepared from meso- or rac-lactide are in general amor-
phous, but by applying stereoselective catalyst, polymers having
tacticity high enough for crystallization have been obtained [10]. The
melt enthalpy estimated for an enantiopure PLA of 100% crystallinity
(ΔH°m) by Fischer et al. [64], were 93 J/g, is the valuemost often referred
to in the literature although higher values (up to 14 t J/g) also have been
reported [65]. The Tm and degree of crystallinity are dependent on the
molarmass, thermal history, and purity of the polymer, and the crystal-
lization kinetics, andmelting behavior of PLAs of different optical purity
has been investigated in several studies [66–68]. It has been observed
that an optical purity of at least 72–75%, corresponding to about 30 iso-
tactic lactyl units, is required for the crystallization to take place [66].
Though, Sarasua et al. [69] have been able to crystallize a PLA of as
low as 43% optical purity, when polymerizing using Salen-Al-OCH3 (a
complex resultingwhen reacting a Schiff base on AlEt2Cl) as an initiator,
whichwas explained by the preference for the formation of long isotac-
tic sequences. Enantiomeric oligomers of fewer lactyl units only showed
a molar mass dependent Tg. By utilizing stereoselective catalysts in the
polymerization, semicrystalline polymers have been prepared both
from meso-lactide [70] and rac-lactide [71,72]. After annealing, a Tm of
152 °C was obtained for the meso-PLA. The rac-PLA prepared by usingperties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
Table 2
Physical properties of PLA and various biopolymers.
[48].
Propertiesa Type of biopolymer
Unit PLA PLLA PDLLA PGA PDLLA/PGA 50/50 PDLLA/PGA 50/50 PCL PHB
ρ g/cm3 1.21–1.25 1.24–1.30 1.25–1.27 1.50–1.71 1.30–1.40 1.3 1.11–1.146 1.18–1.262
σ MPa 21–60 15.5–150 27.6–50 60–99.7 41.4–55.2 41.4–55.2 20.7–42 40
E GPa 0.35–3.5 2.7–4.14 1–3.45 6.0–7.0 1–4.34 1.38–4.13 0.21–0.44 3.5–4
ε % 2.5–6 3.0–10.0 2.0–10.0 1.5–20 2.0–10.0 2.5–10 300–1000 5.0–8.0
σ* Nm/g 16.8–48.0 40.0–66.8 22.1–39.4 40.0–45.1 30.9–41.2 31.8–42.5 18.6–36.7 32.0–33.9
E* kNm/g 0.28–2.80 2.23–3.85 0.80–2.36 5.00–4.51 0.77–2.14 1.06–2.12 0.19–0.38 2.80–2.97
Tg °C 45–60 55–65 50–60 35–45 40–50 50–55 (−60)–(−65) 15.0–5.0
Tm °C 150–162 170–200 amb 220–233 am am 58–65 168–182
a ρ— Polymer density, σ— tensile strength, E— tensile modulus, ε— ultimate strain, σ*— speciﬁc tensile strength, E*— speciﬁc tensile modulus, Tg — glass transition temperature and
Tm — melting temperature.
b am — amorphous and thus no melt point.
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191 °Cwith aΔH of 42 J/g [71]. The high Tmwas believed to be the result
from co-crystallization of enantiomerically pure D- and L-PLA leading to
a stereocomplex formation. PLA stereocomplexes were ﬁrst reported by
Ikada et al. [73], when they discovered that the Tm of blended PLLA and
PDLA is about 50 °C higher than for the pure enantiomeric polymers.
Since that, stereocomplexes have been further investigated for both
PLA oligomers and high molar mass polymers [74–76]. Table 3 lists
the effects of stereochemistry and crystallinity on themechanical prop-
erties of amorphous L-PLA, annealed L-PLA, and amorphous D,L-PLA
[5,77]. Perego et al. [78] studied the effects of Mw and crystallinity on
the mechanical properties of PLA by polymerizing pure L-lactide and
D,L-lactide to create amorphous or semicrystalline polymers. They
found that the Tgwasn't greatly affected by the stereo chemical makeup
or the range of Mws tested and that PLAwith aMw of 22,000 g/mol has
a Tg of 55 °C, which is only 4–5 °C lower than that predicted for PLA of
inﬁniteMw [5,78]. Other physical properties can be important including
transparency/opacity, color (some items might use color to aid in iden-
tiﬁcation), esthetics, water absorption, lubricity, and wear resistance.
Most of these properties are oriented to speciﬁc applications and the
data were too fragmentary to be included in the tables and graphs.
2.2. Mechanical properties
The mechanical properties of lactic acid-based polymers can be var-
ied to a large extent ranging from soft and elastic plastics to stiff and
high strengthmaterials. Semicrystalline PLA is preferred over the amor-
phous polymer when higher mechanical properties are desired. Semi-
crystalline PLA has an approximate tensile modulus of 3 GPa, tensile
strength of 50–70 MPa, ﬂexural modulus of 5 GPa, ﬂexural strength of
100 MPa, and an elongation at break of about 4% [10,79].
Different from thermal properties, the mechanical properties and
crystallization behavior of PLA are very dependent on the Mw andTable 3
Effects of stereochemistry and crystallinity on mechanical properties.
[5,77,78].
Properties Annealed
PLLA PLLA PDLLA
Tensile strength MPa 59 66 44
Elongation at break % 7 4 5.4
Modulus of elasticity MPa 3750 4150 3900
Yield strength MPa 70 70 53
Flexural strength MPa 106 119 88
Unnotched izod impact J/m 195 350 150
Notched izod impact J/m 26 66 18
Rockwell hardness 88 88 76
Heat deﬂection temperature °C 55 61 50
Vicat penetration °C 59 165 52
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shown that tensile modulus of PLLA increases by a factor of 2 when
the Mw is raised from 50 to 100 kDa [10], and tensile strengths of
15.5, 80 and 150 MPa, for varying the Mw from 50 over 150 to
200 kDa respectively [48]. On the other hand, the stereo chemical
makeup is very easily controlled by the polymerization with D-lactide,
L-lactide, D,L-lactide, or meso-lactide, to form random or block
stereocopolymers, while the Mw is directly controlled by the addition
of hydroxylic compounds (i.e., lactic acid, water, alcohols) [77]. The abil-
ity to control the stereochemical architecture allows precise control
over the speed and degree of crystallinity, the mechanical properties,
and the processing temperatures of the material.
Pure PDLA or PLLA has a crystalline equilibrium Tm of 207 °C but
typical Tm are in the 170–180 °C range [80]. This is due to small and
imperfect crystallites, slight racemization, and impurities. It has also
been observed that a 1:1 mixture of pure PLLA with pure PDLA will
yield an insoluble gel formed by the stereocomplexation (racemic
crystallite) of the two polymers during crystallization or polymerization
[75,76]. Superior mechanical properties have been achieved by
stereocomplexation of enantiomeric PLAs, which was ascribed to for-
mation of stereocomplex crystallites giving intermolecular crosslinks.
This pure stereocomplex has a Tm of 230 °C and mechanical properties
greater than either pure polymer [5,75,76,81]. Using low Mw PLA, it
has been reported that ultimate tensile strengths were 50 MPa for the
1:1 stereocomplex versus 31 MPa for pure L-PLA. Variations such as
block and star copolymers of D- and L-lactide show this same
stereocomplexation [77].
In the early 90's, Lalla and Chugh polymerized D,L-lactide using 2%
(w/v) and 0.1% (w/v) zinc oxide and stannous chloride catalyst systems,
respectively, and having studied their mechanical properties [82]
(Table 4), they found that the wide variance in the oriented properties
is due to the degree of orientation and stereo chemical composition of
various PLA samples. Table 3 lists the effects of stereochemistry andTable 4
Comparison of physical properties of high Mw PLA.
[5].
Properties Unoriented Orienteda
Ultimate tensile
strength
psi ∗ 103, MPa 6.9–7.7, 47.6–53.1 6.9–24, 47.6–166
Tensile yield
strength
psi ∗ 103, MPa 6.6–8.9, 45.5–61.4 N/A
Tensile modulus psi ∗ 103, MPa 500–580, 3447–4000 564–600, 3889–4137
Notched izod
impact
ft-lb./in 0.3–0.4 N/A
Elongation at break % 3.1–5.8 15–160
Rockwell hardness 82–88 82–88
Speciﬁc gravity g/cm3 1.25 1.25
Tg °C 57–60 57–60
a Results depend on degree of orientation and isomer content.
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Table 5
DSC parameters for the thermal transitions observed concerning injected (PLA-I) and ex-
truded/injected (PLA-EI) materials (without/with-A-annealing).
[140].
Sample Heating Tg (°C) Cold Crystallization Melting XRD
Tc (°C) Xc-c (%) Tc (°C) Xc-c (%) Xc (%)
PLA-I 1st 65 125 4.1 154 4.5
PLA-I 2nd 64 133 0.3 156 0.3
PLA-IA 1st 67 – – 154 33 45.1
PLA-EI 1st 64 128 8.4 154 7.8
PLA-EI 2nd 64 133 2 156 1.9
PLA-EIA 1st 68 – – 154 34.5 47.3
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PLLA, and amorphous PDLLA. On annealing, the impact resistance in-
creased due to the crosslinking effects of the crystalline domains,
while the tensile strength increased, presumably due to the stereo reg-
ularity of the chain [77,78].
Themechanical properties of PLA that are themost intensively stud-
ied in comparison to a series of biopolymers include tensile properties:
tensile strength (σ, in MPa), tensile modulus (E, in GPa) and ultimate
strain (ε, in %) and polymer density (ρ, in g/cm3). Data summary are
given in Table 2 [48]. It has been found that tensile properties are clearly
best for the densest reported polymers, especially for poly(glycolic acid)
(PGA). PCL, on the other hand, seems to be the weakest polymer with a
remarkable high strain at failure. The data on ﬂexural propertieswas too
limited to be used for comparison.However,ﬂexural and tensile proper-
ties are mostly correlated anyway and the tendencies found here are
probably the same as found when comparing ﬂexural properties [48].
PLA-speciﬁc mechanical properties — speciﬁc tensile strength (σ*,
in Nm/g) and speciﬁc tensile modulus (E*, in kNm/g) are obtained by di-
viding the original mechanical properties by the polymer density: In
Table 2, PLA speciﬁc tensile strength and tensile modulus ranges com-
pared to different biopolymers are given. It is a useful tool in the case of
intending to use the biopolymers as structural elements without needing
reinforcement. These speciﬁc properties are important as they determine
the dimensions necessary for a certain mechanical strength or stiffness.
Contrary to usefulness as a composite matrix, in this case, PGA and PLLA
seem the best choices, whilst PCL and also polyhydroxybutyrate (PHB,
σ* 8.8 MPa and E* 7.8 MPa) are clearly the worst ones [48].
It should be emphasized that themechanical properties of polymers
of similarMw, but prepared by different polymerization processes, have
been shown not to differ. This has been noticed for PLAs prepared by
both polycondensation and ring-opening polymerization [83].
3. PLA property variation during
3.1. Processing, thermal degradation and recyclability
Although PLA can be processed on standard converting equipment
with minimal modiﬁcations, its unique properties must be taken into
consideration in order to optimize the conversion of PLA to molded
parts, ﬁlms, foams, and ﬁbers, etc. Several processing technologies for
PLA have been developed for large-scale production lines, depending
on the intended application, including drying and extrusion [8,84],
injection molding [85–87], injection stretch blow molding [2,88,89],
casting (ﬁlm and sheet) [89–91], extrusion blown ﬁlm [92–94],
thermoforming [47,95,96], foaming [97–102], ﬁber spinning [103–
107], electro spinning [108–116], blending [117–120], compounding
[11,121–124] and nanocompositing [125–137]. Lim et al. [138] report-
ed, in a comprehensive study, on these techniques for PLA processing
highlighting the large scale production challenges and performance im-
provements. Due to the fact that the ﬁrst 4 aforementioned techniques
are themost commonprocessing technologies and themost studied,we
have focused on these techniques for highlighting the thermal and me-
chanical PLA changes during processing.
Processing effects on PLA is an important issue and independent re-
searchﬁeld where the polymermust possess adequate thermal stability
to prevent degradation of its Mw and physical properties. PLA un-
dergoes thermal degradation at temperatures above 200 °C (392 °F)
and by hydrolysis, lactide reformation, oxidative main chain scission,
and inter- or intramolecular transesteriﬁcation reactions. PLA
degradation is dependent on time, temperature, low-Mw impurities,
and catalyst concentration [5]. Catalysts and oligomers decrease the
degradation temperature and increase the degradation rate of PLA. In
addition, they can cause viscosity and rheological changes, fuming dur-
ing processing, and poor mechanical properties. PLA homopolymers
have a Tg and Tm of about 55 °C and 175 °C, respectively. They require
processing temperatures in excess of 185–190 °C [139]. At thesePlease cite this article as: S. Farah, et al., Physical and mechanical pro
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Mw, as well as thermal degradation, are known to occur. Consequently,
PLA homopolymers have a very narrow processing window. The most
widely used method for improving PLA processability is based on Tm
depression by the random incorporation of small amounts of lactide en-
antiomers of opposite conﬁguration into the polymer (i.e., adding a
small amount of D-lactide to the L-lactide to obtain PDLLA). On the
other hand, unfortunately, the Tm depression is accompanied by a signif-
icant decrease in crystallinity and crystallization rates [139].
Maspoch and coworkers [140] extensively studied the chemical
structure, crystallinity, thermal stability and mechanical properties of
PLA after being processed bymeans of industrial thermoplastic process-
ing methods (injection and extrusion followed by injection) with or
without a further thermal treatment (i.e. annealing) (Table 5). They
found that processing of PLA was responsible for a decrease in Mw, as
determined by GPC, due to chain scission. The degree of crystallinity
was evaluated by means of DSC and X-ray diffraction. It was found
that mechanical processing led to the quasi disappearance of crystal
structure whereas it was recovered after annealing. By analyzing 1H
NMR and 13C NMR chemical shifts and peak areas, it was possible to af-
ﬁrm that the chemical composition of PLA did not change after process-
ing, but the proportion of methyl groups increased, thus indicating the
presence of a different molecular environment. The thermal stability
of various materials was established by calculating characteristic tem-
peratures from thermograms and conversion derivative curves. Finally,
the mechanical behavior was determined by means of tensile testing
(Young's modulus, yield strength and elongation at break). They
found that fast cooling after injectionmoldingdid not allow thepolymer
chains to rearrange into a crystalline structure. For this reason,
presupposed bandswere not present for injected and extruded/injected
materials. On the contrary, after annealing, an important crystalline
structure was created. These ﬁndings were corroborated by DSC
(degrees of crystallinity of 4% for injected material, 8% for extruded/
injectedmaterial and 33–35% for annealedmaterials) and X-ray diffrac-
tion (45–47% for annealedmaterials). Thermal decomposition occurred
within the temperature range of 325–375 °C. Raw material exhibited
slightly higher thermal stability (~331 °C) than processed materials
(323–325 °C) (Table 5). After annealing, samples showed an increase
in Young's modulus (5–11%) and in yield strength (15–18%), which is
explained by the higher degree of crystallinity of annealed materials,
with its subsequent decrease in chainmobility. Extruded/injectedmate-
rials showed a signiﬁcant increase in elongation at break (32–35%
higher), compared to injectedmaterials. It is attributed to a higher num-
ber of chains, due to chain scissions in reprocessed materials, Table 6.
For the case of injection molding of PLA a Mw decrease of 14–40%
was reported [78]. Coupled extrusion and injectionmolding also result-
ed in a Mw reduction. As found by viscosity studies using the Mark–
Houwink equation:
η½  ¼ 5:50  10−4 Mv0:639: ð1Þ
Viscosimetric studies revealed that there was a 21.85% and 41.00%
Mw decrease when the PDLLA was injection molded and extruded,perties of PLA, and their functions in widespread applications — A
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Table 6
Mainmechanical properties of processed PLA (Young's modulus, yield strength and elon-
gation at break) processed by injection (PLA-I) and extrusion/injection (PLA-EI) without
or with annealing (PLA-EIA).
[140].
Property Unit PLA-I PLA-EI PLA-IA PLA-EIA
E GPa 3.7 ± 0.1 3.9 ± 0.1 4.1 ± 0.1 4.1 ± 0.1
σy MPa 65.6 ± 1.3 65.2 ± 0.9 75.4 ± 0.9 77.0 ± 1.1
εb % 4.0 ± 0.8 5.4 ± 0.6 2.5 ± 0.2 3.3 ± 0.3
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average Mw of the injection-mold-grade PDLLA is that during process-
ing there was polymer chain entanglement, which led to an increase
in the hydrodynamic volume, intrinsic viscosity, and, hence, the Mw
of the polymer.
Bigg [141] reported the effect of temperature on the degradation of
PLA and its copolymers. PLA quickly loses its thermal stability when
heated above its Tm. A signiﬁcant level of molecular degradation oc-
curred when PLA was held 10 °C above its Tm (~160 °C) for a sustained
period of time, Fig. 4. Migliaresi and coworkers showed that thermal
degradation was due to chain splitting and not hydrolysis. They ob-
served Mw reductions greater than 50% and concluded that large Mw
reductions were unavoidable. Oxidation of PLA didn't occur to a mea-
surable extent during thermal degradation [142].
The PLLA has a narrow window of processing, (12 °C), whereas a
10/90 PDLLA copolymer has a much wider range of processing (40 °C)
due to its lower Tm. Bigg [141] reported tables, graphs, and DSC thermo-
grams of various investigated PLA samples following processing
methods. The effect of temperature on the Mw of PLA, and processing
conditions on the mechanical properties of PLA are summarized in
Fig. 4 and Table 7 respectively.
PLA Thermal degradation— One of the drawbacks of processing PLA
in the molten state is its tendency to undergo thermal degradation,
which is related both to the process temperature and the residence
time in the extruder and hot runner. PLA is thermally unstable and ex-
hibits rapid loss of Mw and consequent erosion of its mechanical prop-
erties as well. PLA thermal degradation partially starts at temperatures
lower than the Tm of the polymer, but the degradation rate rapidly in-
creases above the Tm. The ester linkages of PLA tend to degrade during
thermal processing or under hydrolytic conditions [143].
Different factors like particle/device size and polymer shape,
temperature, moisture, crystallinity, % D-isomer, residual lactic acidFig. 4. Effect of temperature on the molecular weight (Mw) and num
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purities from the catalyst will affect the polymer degradation rate [3].
Thermal degradation of PLA is very complex and various mechanisms
have been postulated, including various non-radical and radical
reactions including random chain scission reactions, depolymerization,
oxidative degradation, intramolecular and intermolecular transesteri-
ﬁcations, hydrolysis, pyrolytic elimination and radical reactions [5,17,
144–148]. The degradation of PLA during the melt is mainly caused by
intramolecular transesteriﬁcation reactions leading to cyclic oligomers
of lactic acid and lactide. Simultaneously, there is a recombination of
the cyclic oligomers with linear polyesters through insertion reactions,
while molecules with longer chain lengths are favored. In the case of in-
termolecular transesteriﬁcation, a reaction between two ester mole-
cules exchanges their radicals, thus leading to a variation of the
distribution of Mws [140]. Only a few studies considered the intermo-
lecular transesteriﬁcation [149,150] as a mechanism present during
degradation in themelt,which can beminimized by the addition of ben-
zoyl peroxide [151], 1,4-dianthraquinone [152] and other stabilizers.
Kopinke et al. proposed that above 200 °C, PLA can degrade through
intra- and intermolecular ester exchange, cis-elimination, radical and
concerted non-radical reactions, resulting in the formation of CO, CO2,
acetaldehyde and methylketene [138,153]. In contrast, McNeill and
Leiper proposed that thermal degradation of PLA is a non-radical, “back-
biting” ester interchange reaction involving the –OH chain ends [152].
Depending on the point in the backbone at which the reaction occurs,
the product can be a lactide molecule, an oligomeric ring, or acetalde-
hyde plus CO (Fig. 5). The formation of acetaldehyde is expected to in-
crease with increasing process temperature due to the increased rate
of the degradation reactions. Above 230 °C a thermal degradation of
acetaldehyde was reported by McNeill and Leiper [152], involving a
complex chain reaction to form methane and CO at the elevated tem-
perature (Fig. 5). McNeill and Leiper also proposed that the formation
of butane-2,3-dione, another detected byproduct, is likely caused by
the radical combination of acetyl radicals from the chain reaction
(Fig. 5) [152]. PLA hydrolysis lead to the cleavage of ester linkages,
with the production of acid and alcohol groups. Ester splitting depends
on water content, while pyrolytic elimination leads to the formation of
an acid and a molecule with acrylic end groups. This is a less important
side reaction [140]. The pyrolytic elimination results in species contain-
ing conjugated double bonds due to the carbonyl groups [147]. PLA rad-
ical degradation only needs be taken into consideration at temperatures
above 250 °C. These reactions can be assumed to start with either an
alkyl-oxygen or an acyl-oxygen homolysis [153].ber-average molecular weight (Mn) of 90/10 PLA copolymer.
perties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
Table 7
Effect of processing conditions on the mechanical properties of PLA copolymers.
[5,141].
Copolymer ratio (L/D,L)-PLA Process condition Tensile strength, MPa Young's modulus, GPa Elongation, % Mw, g/mol
100/0 Injection molded, crystallized 64.8 4 – 800,000
90/10 Injection molded, amorphous 53.4 1.03 4.6 –
90/10 Injection molded, crystallized 58.6 1.29 5.1 –
90/10 Extruded, biaxially oriented, strain crystallized 80.9 3.41 41.2 145,000
90/10 Extruded, biaxially oriented, strain crystallized, heat set 70.1 2.76 20.7 145,000
95/5 Extruded, biaxially oriented, strain crystallized 68.6 1.88 56.7 120,000
95/5 Extruded, biaxially oriented, strain crystallized, heat set 60.7 1.63 63.8 120,000
80/20 Injection molded, amorphous 51.7 2.1 5.7 268,000
80/20 Extruded, biaxially oriented, strain crystallized 84.1 2.94 18.2 268,000
80/20 Extruded, biaxially oriented, strain crystallized, heat set 80.1 2.54 32.3 268,000
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scribe the Mw and polydispersity index (PDI) in PLA thermal degrada-
tions. They claimed model ability to predict these parameters changes
for PLLA assigned for thermal degradation. Their model was based on
the random chain scission mechanism, effects of temperature, and
time on the Mw and PDI.
PLA recycling — PLA thermo-mechanical recycling has been exten-
sively studied. The general trend is a slight decrease of its mechanical
properties after several injections or molding processes according to
the nature of the polymer [140]. The major problem of recycling is the
thermal stability of PLA, which has been reported as a complex process
[154]. This serious issue raises the question of recyclability of industrial
production waste and packaging wastes as well. Grohens and co-
workers reported on the evolution of rheological and mechanical prop-
erties of polymer with the number of recycling cycles up to 7 cycles
[155]. They found that only the tensile modulus remains constant
with the thermo-mechanical cycles. In contrast, stress and strain at
break, rheological factors and the modulus and hardness probed by
nanoindentation decrease for PLA (Table 8). Stress at break was found
to decrease from 66.5 to 56.0 and 23.0 MPa, and strain at break from
0.060 to 0.025 and 0.005 mm/mm after 3 and 7 injection cycles respec-
tively [155]. This dramatic effect is ascribed to a large decrease in the
Mw due to several different complex degradation processes which are
discussed (Fig. 6). Reprocessing of PLA induces an increase of crystalli-
zation during cooling with the number of injection cycles. This can be
explained by higher chain mobility due to chain scission during injec-
tion (Table 9). The addition of stabilizers suppresses this crystallization
during cooling. Moreover, most of the mechanical performances of PLAFig. 5. Thermal degr
Adapted from McNe
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This decrease could be explained by the strong degradation of PLA dur-
ing processing which yields large chain scission evidenced by rheologi-
cal experiments and Mwmeasurements (Fig. 6 and Table 8).
Several solutions have been studied to avoid this issue mainly to
minimize the PLA thermal degradation by several routes: 1) free radi-
cals stabilizer (i.e. Quinone) [155], was found to be an efﬁcient stabilizer
to trap free radicals andmaintain PLA chain lengthwith time at the pro-
cessing temperatures. 2) Reinforcement biocomposite (i.e. ﬂax ﬁbers
20 ≤ X b 30%) as reported by Endo and coworkers [154]. They have
found that Flax/PLLA biocomposites have been shown to be very prom-
ising biocomposites and exhibit interesting recycling properties, espe-
cially if it can be considered that in the industrial process recycled
material would include both virgin and recycled matter (Tables 8
and 9). Furthermore, with natural ﬁbers as reinforcement end-of-life
composting is possible. Finally, PLA industrialwaste can supportmoder-
ate recycling as well as other polyesters which is a signiﬁcant improve-
ment of the environmental impacts of this polymer. Although to be
complete, biodegradation of this stabilized or reinforced PLA has to be
conﬁrmed in forthcoming studies.
3.2. Biodegradation
Polymer degradation occurs mainly through scission of the
main chains or side chains of macromolecules. In nature, polymer
degradation is induced by thermal activation, hydrolysis, biological ac-
tivity (i.e., enzymes), oxidation, photolysis, or radiolysis [156]. Biodeg-
radation has been accomplished by synthesizing polymers that haveadation of PLA.
ill and Leiper [152].
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Table 8
Evolution of mechanical properties of ﬂax/PLLA biocomposites at different ﬁber contents during recycling.
Mechanical properties after Mechanical properties Material
PLLA Flax/PLLA biocomposites (20%) Flax/PLLA biocomposites (30%)
1 cycle E (MPa) 3620 ± 67 6395 ± 515 7320 ± 380
σ (MPa) 60.1 ± 1.7 55.5 ± 4.1 53.1 ± 2.8
ε (%) 2.4 ± 0.4 1.4 ± 0.2 1.1 ± 0.1
6 cycles E (MPa) 3518 ± 192 5633 ± 247 6760 ± 183
σ (MPa) 27.8 ± 8.9 29.8 ± 3.9 16.3 ± 2.7
ε (%) 0.9 ± 0.4 0.7 ± 0.1 0.2 ± 0.1
Evolution of mechanical properties cycles 1 to 6 (%) E (MPa) −2.8 −12 −7.7
σ (MPa) −53.8 −46.3 −69.4
ε (%) −72.5 −47.6 −77.7
10 S. Farah et al. / Advanced Drug Delivery Reviews xxx (2016) xxx–xxxhydrolytically unstable linkages in the backbone. The most common
chemical functional groups are esters, anhydrides, orthoesters, and am-
ides [157]. As a polyester, PLA's biodegradation behavior is a critical
characteristic of the material and the most important reason for the
high interest in its use in medical applications and industry. PLA degra-
dation was studied in animal and human bodies for medical applica-
tions like implants, surgical sutures, and drug delivery materials. In
these environments, PLA is initially degraded by hydrolysis and the sol-
uble oligomers formed are metabolized by cells [44]. As illustrated in
Fig. 7A, cleavage of the ester linkages by absorbedwater produces a suc-
cessive reduction in Mw. The rate of this hydrolytic degradation is pri-
marily temperature- and humidity-dependent. Fig. 7A also illustrates
the rate of hydrolytic degradation as a function of temperature [12].
PLA has a relatively long half-life of hydrolysis due to steric effects
where the alkyl group hinders the attack by water, for example, PLLA
stent or ﬁbers exposed to in vivo conditions do not begin to degrade
until after approximately 12 months [158,159]. On the other hand,
PLA degradation upon disposal in the environment (environmental
degradation) is more challenging because PLA is largely resistant to at-
tack bymicroorganisms in soil or sewage under ambient conditions. The
polymer must ﬁrst be hydrolyzed at elevated temperatures (about
60 °C) to reduce the Mw before biodegradation can commence. Under
conditions of high temperature and high humidity, as in active compost,
for example, PLA will degrade quickly and disintegrate within weeks to
months [8]. The primary mechanism of degradation occurs by a two-
step process starting also with hydrolysis, followed by bacterial attack
on the fragmented residues. During the initial phases of degradation,
the high Mw polyester chains hydrolyze to lower Mw oligomers. As
the average Mw reaches approximately ~10,000 Da, micro-organisms
present in the soil begin to digest the lower Mw lactic acid oligomers,
producing carbon dioxide and water (Fig. 7B) [12]. The rate of hydroly-
sis is accelerated by acids or bases and is dependent onmoisture content
and temperature. PLA products rapidly degrade in both aerobic and an-
aerobic composting conditions [8].
The process is also dependent upon the chemical and physical
characteristics of the polymer. These include diffusivity, porosity,Fig. 6. Evolution of molecular weight (Mw) and of PLLA as a function of injection cycles.
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strength, thermal tolerance, and resistance to electromagnetic radiation
in some cases [160]. PLA degradation has been found to be dependent
on a range of factors, such as Mw, crystallinity, purity, temperature,
pH, presence of terminal carboxyl or hydroxyl groups,water permeabil-
ity, and additives acting catalytically thatmay include enzymes, bacteria
or inorganic ﬁllers [161]. Under typical use conditions, PLA is very stable
and will retain its Mw and physical properties for years. This is typiﬁed
by its growing use in clothing and durable applications. HighMw PLA is
also naturally resistant to supporting bacterial and fungal growth,
which allows it to be safely used for applications such as food packaging
and sanitation. A review done by Tsuji gives an excellent account of PLA
degradation studies [23].
For implantable medical devices, once implanted in the body, the
biodegradable device should maintain mechanical properties until it is
no longer needed and then be degraded, absorbed, and excreted by
the body, leaving no trace. However semi-crystalline PLA biodegrada-
tion occurs in two phases. In the ﬁrst phase, water penetrates the bulk
of the device, preferentially attacking the chemical bonds in the amor-
phous phase (due to the ability of water to permeate within the amor-
phous phase but not the crystalline phase) and converting long
polymer chains into shorter, ultimately water-soluble fragments. Be-
cause this occurs in the amorphous phase initially there is a reduction
in Mw without a loss in physical properties as the device matrix is still
held together by the crystalline regions. The reduction in Mw is soon
followed by a reduction in physical properties as water begins to frag-
ment the device [62]. Yield strain, yield stress, and elongation to failure
all decrease. These changes can have consequences for devices which
are load bearing throughout their degradation process [162]. In the sec-
ond phase, enzymatic attack of the fragments occurs. The metabolizing
of the fragments results in a rapid loss of polymer mass (illustrated by
Fig. 8) [62].
However stereochemistry, crystallinity, Mw, and applied loads are
the main factors inﬂuencing the rate of degradation of PLA [163]. The
degradation–absorption mechanism is the result of many interrelated
factors, including 1) the chemical stability of the polymer backbone,
2) the presence of catalysts, 3) additives, impurities or plasticizers,
4) the geometry and location of the device. The balancing of these fac-
tors to tailor an implant to slowly degrade and transfer stress to the sur-
rounding tissue as it heals at the appropriate rate is one of the major
challenges facing researchers today [62].
The factors which accelerate polymer degradation are the following:
1) More hydrophilic monomer. 2) More hydrophilic, acidic end groups.
3) More reactive hydrolytic group in the backbone. 4) Less crystallinity.
5) Smaller device size. The location of the device can play an important
role in the degradation rate of implants. Large devices implanted in
areaswith poor vascularizationmaydegrade and overwhelm the body's
ability to ﬂush away degradants. This leads to a buildup of acidic by-
products. An acidic environment will catalyze the further degradation
and cause further reduction in pH and may also be responsible for ad-
verse tissue reactions [164]. It has recently been shown that the rate
of degradation is also dependent on themagnitude of the applied stressperties of PLA, and their functions in widespread applications — A
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Table 9
Evolution of thermal properties of PLLA, ﬂax/PLLA biocomposites 20% and 30% as a function of injection cycles [154].
Material Injection cycles Tg (°C) First cooling Second heating
Tc (°C) ΔHc (J/g) Tc (°C) ΔHc (J/g) Tm (°C) ΔHm (J/g) χ (%)
PLLA 1 66.5 – – 123.3 36.5 175.1 36.3 38.7
3 59.9 93.6 15.9 104.3 16.4 171.1 38.4 41
6 56.5 97.7 38.9 89.8 0.6 167.3 49.9 53.2
ﬂax/PLLA biocomposites (20%) 1 61.1 – – 110.9 36.5 170.7 37.2 39.7
3 56.9 89.1 16.8 90.4 21.6 167.4 44.2 47.1
6 54.9 92.4 41.3 – – 163.9 47.1 50.2
ﬂax/PLLA biocomposites (30%) 1 62.2 114.5 45.6 – – 170.4 44.0 47
3 57.8 112.5 45.6 – – 163.4 51.9 55.3
6 41.7 87.1 35.9 85.1 5.1 152.3 40.2 43.2
Tg, Tc, ΔHc, Tm, ΔHm and χ represent, respectively, the glass transition temperature, the crystallization temperature, the crystallization enthalpy, the melting temperature, themelting en-
thalpy and the degree of crystallinity.
11S. Farah et al. / Advanced Drug Delivery Reviews xxx (2016) xxx–xxx[165]. Implants under stress degrade faster. It was proposed that the
stressed implant may form microcracks increasing the surface area ex-
posed to water [164].
Lactide commercially available devices and sutures degrade by bulk
erosion [166]. This two-stage degradation mechanism has led one re-
searcher to report that the degradation rate at the surface of large
lactide-glycolide implants is slower than the degradation in the interior
[62]. Initially, degradation does occurmore rapidly at the surface due to
the greater availability of water. The degradation products at the surface
are rapidly dissolved in the surrounding ﬂuid and removed from the
bulk polymer. In the interior of the device the inability of large polymer-
ic degradation products to diffuse away from the bulk device results in a
local acidic environment in the interior of the implant. The increased
acidic environment catalyzes further degradation resulting in accelerat-
ed hydrolysis of the ester linkages in the interior. Athanasiou and co-
workers [167] showed that low-porosity implants from 50/50 PDLLG
degrade faster than high-porosity implants. They have attributed this
to the quick diffusion of low pH degradants from the interior of the
high-porosity devices. Polymer scientists have used this knowledge to
tailor the degradation rates of biodegradable polymers. Hydrolysis of
the crystalline domain occurs mainly by a surface erosion mechanism.
Bulk hydrolysis occurs faster than surface hydrolysis. PLA ﬁrst degrades
in the more loosely packed chain folding regions. In the later stages of
hydrolysis, the more persistent crystalline region's Mw approaches
that of the lamellar thickness, and the degradation mechanism will
change to that of surface erosion [8].Fig. 7. (A) Hydrolysis of PLA and length of time taken to degrade to PL
(Adapted from [12]).
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hydrolysis, including lactide and oligomers and some acidic and basic
additives. Strategies for stabilizing PLA to hydrolysis include reducing
the level of residual monomer to as low a level as possible and lowering
the water concentration in PLA and preventing autocatalysis. The equi-
librium moisture content can be decreased by controlling morphology
(highly crystalline, oriented, ﬁbular structure). Reduction in the rate of
autocatalysis has been accomplished by incorporation of basic, buffering
salts such as CaCO3 [8]. A second approach to preventing autocatalysis
was reported by Lee et al. [168] by functionalizing the PLA end group
chemistry. End groups studied included OH–, COOH–, Cl–, and NH2–.
NH2- and Cl-terminated PLAs were more resistant to thermal and hy-
drolytic degradation. The thermal stability of the OH-terminated PLA
was poor (likely due to lactide formation), and the hydrolytic stability
of the COOH-terminated PLAwas also poor. Alternatively, storage stabil-
ity, at lower temperatures and/or lower humidities of the PLA products
are considered to be acceptable [12].
Tsuji and Suzuki also studied stereocomplex degradation over the
course of 30 months, in 7.4 pH buffer solution using 1:1 blends and
nonblended ﬁlms prepared from PLLA and PDLA [169]. Properties and
Mw were monitored with GPC, tensile tests, DSC, SEM, optical polariz-
ing microscopy, x-ray diffractometry, and gravimetry. They found that
the rate of Mw loss, tensile strength, Young's modulus, melting temper-
ature, and mass remaining of the ﬁlms in the course of hydrolysis was
more stable for the stereocomplex ﬁlm than for the nonblended ﬁlms
[169].A in water. (B) Biodegradation of polylactic acid in 60 °C compost.
perties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
Fig. 8. Generic curves showing the sequence of polymer-molecular weight (Mw),
strength, and mass-reduction over time.
(Adapted from [62]).
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Packagingmaterials need to show sufﬁcient ﬂexibility and resilience
to compensate for the reduction in volume to preventing irreversible
deformations [170]. A big effort for reducing packaging waste has en-
couraged the exploration of new bio-based packaging materials, such
as edible and biodegradable ﬁlms from renewable resources. Unfortu-
nately, so far the use of biodegradable ﬁlms for packaging applications
has been strongly limited because of the poor barrier properties and
weakmechanical properties shown by natural polymers. For this reason
natural polymers were frequently blended with other synthetic poly-
mers or, less frequently, chemically modiﬁed with the aim of extending
their applications in more special or severe circumstances [170]. PLA
offer numerous opportunities in packaging applications. So far, theTable 10
Summary of PLA modiﬁcations for packaging applications.
Type of modiﬁcation Treatment or added material Effect
Modiﬁer Citrate esters ↓Tg and improv
Triacetine or tributyl citrate ↓Tg and ↑crysta
Oligomeric malonate esteramides ↓Tg and improv
4,4-Methylene diphenyl diisocyanate ↑Tg to 64 °C, ↑te
Polyglycerol esters Improving the e
Polyethylene glycol and acetyl triethyl citrate ↓Tg and ↑crysta
Talc ↑Ductility at m
Bifunctional cyclic ester Enhance PLA to
Poly(1,3-butylene adipate) ↓Storage modu
Polycarbodiimide Improve the th
Blending with: Polyvinyl acetate ↑Tensile streng
Poly ethylene oxide (PEO) Elongation at b
Poly ε-caprolactone (PCL) High improvem
Poly ethylene glycol (PEG) Enhance the cry
Starch with different plasticizers Lowering the p
Polyvinyl alcohol and starch ↑Tensile streng
Ethylene vinyl alcohol (EVOH) Improvement o
Polycarbonate Improvement o
Polyethylene glycidylmethacrylate (PEGMA) Production of s
Copolymerization
of PLA and:
DL-mandelic acid ↑Tg and improv
ε-Caprolactone Improving the d
Polyvinyl chloride Improving stren
Acrylonitrile butadiene styrene Improved impa
and tensile stre
Physical treatment Vacuum compression-molding and solid-state
extrusion techniques
Flexural strengt
8.4 GPa, respec
Orientation Signiﬁcant imp
Annealing ↑Toughness
Aging ↑Tg
Drawing Improvement in
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hampered by its high cost as well as low performances.
In the ﬁeld of packaging, 2 speciﬁc areas have received close atten-
tion, namely high-value ﬁlms and rigid-thermoformed containers. PLA
brings a new combination of attributes to packaging, including stiffness,
clarity, dead fold and twist retention, low-temperature heat sealability,
aswell as an interesting combination of barrier properties including ﬂa-
vor, and aroma barrier characteristics. For extending PLA applications,
the properties like impact strength or ﬂexibility, stiffness, barrier prop-
erties, thermal stability, and production costsmust be improved. Gener-
ally, modiﬁers have been studied to improve stiffness at elevated
temperatures, reduce cost, or increase the degradation rate of PLA.
Some efforts of PLAmodiﬁcations in theﬁeld of packaging are presented
in Table 10 [3]. Alternative approaches have been reported alsowith the
help of nanotechnology and providing safe PLA nanocomposites so that
many of its weakness compared to petrochemical-based polymer im-
provement such as gas barrier, mechanical and thermal properties will
be resolved and expand its application [172,173].
Sterilization is an important aspect where many reusable, dispos-
able, packaging and implant materials will need to be sterilized before
use [4]. For example, in the medical ﬁeld, it is essential to sterilize all
medical implants after fabrication and prior to their surgical placement
to reduce the risk of infections and associated complications [203].
So far various methods for sterilization have been developed like
steam, dry heat, ethylene oxide (EtO), electron beam, γ-radiation, UV,
a combination of these methods or other less-known techniques such
as plasma etching [62,164,166,204]. PLA based polymers in addition to
being susceptible to damage by moisture and radiation, are heat sensi-
tive due to their thermoplastic nature. Thus, the selection of the correct
sterilization technique for PLA for implants is crucial to their physical
and mechanical properties, and hence to their performance in vivo
and in some cases it may cause early implant failure [203]. Accordingly,
PLAs must be able to withstand sterilization conditions and still main-
tain their properties for the intended use [4]. Of particular importance
is hydrolytic stability for steam sterilization, thermal resistance toReference
ing the elongation at break [174]
llinity [175]
ement of the strain at break [176]
nsile strength to 5.8 MPa good nucleating agent for PLA crystallization [177]
longation at break [178]
llization rate [179]
ore than 10% [179]
ughness [180]
lus and Tg but ↑elongation at break [181]
ermal stability at 210 °C for up to 30 min [182]
th and percent elongation [183]
reak of more than 500% [184]
ent in mechanical properties [185]
stallinity of PLA and biodegradability [186]
rice, ↓Tg, and ↑crystallinity and ↑biodegradability [187–189]
th [190]
f mechanical, thermal, and biodegradability properties [191]
f mechanical properties and biodegradation rate [192]
uper-tough PLA materials [193]
ing mechanical properties [194]
ecomposition temperatures and crystallinity [195]
gth and toughness [196]
ct strength and elongation at break with a slight loss in modulus
ngth
[197]
h and ﬂexural modulus were improved up to 221 MPa and
tively.
[198]
rovement in tensile and impact properties [199]
[200]
[201]
tensile and fracture properties [202]
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13S. Farah et al. / Advanced Drug Delivery Reviews xxx (2016) xxx–xxxsteam and autoclave conditions, chemical resistance to EtO, and resis-
tance to high-energy radiation including electron beam, γ, and UV
[205].
In an early study examining the effects of 7 different steam steriliza-
tion techniques on PLLA, it was determined that all the evaluated tech-
niques signiﬁcantly changed at least one material property of the
polymer. TheMwdecreased in all cases, although inmost cases the elas-
tic modulus tended to increase [206]. Autoclaving and dry heating are
usually performed at temperatures equal to or higher than 120 °C. For
example, PLLA at 129 °C for 60 s resulted in minimal change in tensile
properties of the tested PLLA. However, this method resulted in a signif-
icant decrease in the Mw, which would affect the degradation kinetics
of the polymer [4]. PLA and PLGA implants are susceptible to hydrolysis
and their deformation at higher temperatures therefore precludes the
use of these sterilization methods. For radiation sterilization of biore-
sorbable polymers, temperature and dose conditions need to be closely
controlled to avoid chain scission and signiﬁcant degradation. Gamma
sterilization at dry ice temperatures is more preferred [4]. Chemical
sterilization by gases such as ethylene oxide (EO) is often used for poly-
mers that are sensitive to heat and moisture such as the case in PLA
based polymers [203]. However, chemical sterilization can potentially
leave residues in harmful quantities on the surface and within the poly-
mer, so great care is used to ensure that all gas is removed from the de-
vice before ﬁnal packaging usually by extremely long vacuum aeration
times to fully remove the residual EtO gas [62,166]. EtO sterilization is
performed at temperatures of 50–60 °C, which can lead to Mw loss,
and in some cases as well EtO is chemically highly reactive and acts as
a plasticizer for PLA based polymers, which can lead to changes in the
polymer structure. However, detrimental effects of chemical steriliza-
tion on themechanical properties of the PLAbased polymers have rarely
been reported in the literature. Table 11 gives an overview of steriliza-
tion techniques used for PLA based biomaterials and lists their general
advantages and disadvantages [203].
For summary, the speciﬁc effects of different techniques are deter-
mined by the sterilization parameters, the method used for fabrication,
as well as the polymeric composition itself. Thus, it is imperative that
choice of a particular sterilization regimen be made only subsequent
to a careful study. Also, very important for medical devices is steriliza-
tion method compatibility including consideration of single vs. repeat
sterilization [4].3.4. Aging
PLA performance in terms of durability are limited by multiple
chemical aging mechanisms such as thermal decomposition [207,208],
hydrolysis [209,210], photo-oxidation [211,212], natural weathering
[213] and thermo oxidation at high temperature [214,215]. Due to bio-
degradable applications, numerous studies dealing with hydrolytic
aging are available (i.e. [210]). Ideally, composite materials and their
structures that are intended for long term use should be tested in real
time and with realistic in-service environments. Often this is not viable
because the time involved would signiﬁcantly delay product develop-
ment and therefore, accelerated aging techniques are required [216].Table 11
Standard sterilization techniques and their applicability to lactic acid based polymers.
Sterilization
technique
Conditions Advantages
Steam sterilization High steam pressure, 120–135 °C No toxic residues
Dry heat sterilization 160–190 °C No toxic residues
Radiation Ionizing or γ High penetration, low c
and quick effect
Gas sterilization Ethylene oxide Low temperature range
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weather aging on the mechanical and physical properties of neat PLA
and untreated long hemp ﬁber/PLA (AUL) and aligned alkali treated
long hemp ﬁber/PLA (AAL) composites [216]. During accelerated
weathering, measured variables can include exposure time, exposure
to UV irradiation over a speciﬁc wavelength range, and exposure to
moisture as number of cycles or time. In this reported study accelerated
aging was carried out using UV irradiation and water spray at 50 °C for
four different time intervals (250, 500, 750 and 1000 h) and samples
were studied for micro and macroscopic changes. The changes in me-
chanical properties due to accelerated aging for different time periods
are summarized in Table 12. Fig. 9A represents a visual example of the
samples after exposure to accelerated aging environmentswere slightly
deteriorated the surface texture in the form of decoloration, surface
softness andmatrix cracks. A reduction in tensile strength (TS), ﬂexural
strength, Young'smodulus (YM), and ﬂexuralmodulus from theirmean
values for neat PLA and composites with increased aging duration was
observed (Table 12). The greatest overall reduction in TS, ﬂexural
strength, YM, and ﬂexural modulus was observed for AUL composites
than for AAL composites. Impact strength (IS) of neat PLA was found
to decreasewith increased accelerated aging timewhilemode I fracture
toughness (KIc) was found to decrease for all samples with increased
weathering time (Table 12). Foreman and coworkers assumed that
the resulting reduction in TS, ﬂexural strength, YM, and ﬂexural modu-
lus for neat PLA with increased duration of accelerated aging to be due
to plasticization, swelling effect [217] and photochemical degradation
[218]. They also have assumed that the reduction of IS and KIc of neat
PLA with weathering of up to 750 h could be due to PLA chain scission
and formation of surface cracks (sample was found too soft for further
testing), which can be seen in Fig. 9B.
Another comprehensive study was done by Baley and coworkers
[219], where they studied accelerated hygrothermal aging of PLA and
ﬂax/PLA biocomposites where samples were aged in natural seawater
at different temperatures in order to understand the mechanisms
which govern the long-term durability in the marine environment in
order for future adoption for marine structures. During hydrothermal
aging of PLLA the Mw reduction is greater when the temperature and
water uptake increase. Their study continued for 3 months immersion.
Results from mechanical tests on wet unreinforced PLLA are shown in
Table 13. The results indicate that the elastic modulus is not affected
by aging but the tensile strength decreases signiﬁcantly. The results
showed also that ﬂax/PLLA composites undergo permanent changes
after immersion in seawater. According to this study, the absorption of
water was resulted in several degradation mechanisms: hydrolysis (re-
duction in Mw), structural changes, degradation of the ﬁber/matrix
interface, differential swelling at the ﬁber–matrix interface and degra-
dation of ﬁbers and therefore in a reduction in mechanical properties.
The stiffness of unreinforced PLLA was found to hardly be affected by
water, but the biocomposites lose tensile stiffness and strength progres-
sively as water enters the material, suggesting that ﬁber/matrix inter-
face weakening is the main damage mechanism induced by wet aging
[219].
Recently, Fayolle and coworkers have reported PLA aging in atmo-
spheric conditions with the absence of water and UV light [220]. TheyDisadvantages
Deformation/degradation due to water attack, limited usage
for lactic acid based polymers
Melting and softening of polymer, not usable for lactic
acid based polymers
hemical reactivity Instability and deterioration, crosslinking/breakage of
polymer chains
Lengthy process due to degassing residues are toxic
perties of PLA, and their functions in widespread applications — A
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Table 12
Effect of accelerated aging on neat PLA, AUL and AAL composites.
Accelerated Aging (h) Neat PLA
TS (MPa) YM (GPa) FS (MPa) FM (GPa) IS (KJ/m2)
0 48.0 ± 5.0 4.6 ± 1.1 87.4 ± 6.5 3.7 ± 0.3 2.5 ± 0.5
250 45.5 ± 5.0 4.2 ± 1.1 84.1 ± 5.6 2.6 ± 0.4 2.5 ± 0.3
500 42.3 ± 3.3 3.7 ± 1.0 80.0 ± 4.1 2.3 ± 0.6 2.2 ± 0.1
750 28.1 ± 3.3 2.9 ± 0.9 59.8 ± 5.4 1.7 ± 0.4 1.1 ± 0.0
1000 N.T. N.T. N.T. N.T. N.T.
Accelerated Aging (h) AUL PLA
TS (MPa) YM (GPa) FS (MPa) FM (GPa) IS (KJ/m2)
0 60.0 ± 5.1 7.7 ± 1.6 114.9 ± 5.9 5.8 ± 0.8 12.5 ± 3.0
250 53.1 ± 3.0 7.6 ± 1.1 71.1 ± 7.0 2.8 ± 0.7 43.9 ± 5.4
500 41.0 ± 5.0 6.3 ± 1.1 64.1 ± 6.9 2.0 ± 0.7 51.7 ± 3.9
750 36.0 ± 3.9 5.1 ± 0.9 54.2 ± 6.9 1.7 ± 0.5 52.2 ± 5.2
1000 8.1 ± 3.9 1.1 ± 0.4 12.1 ± 4.0 1.5 ± 0.2 18.0 ± 2.5
Accelerated Aging (h) AAL PLA
TS (MPa) YM (GPa) FS (MPa) FM (GPa) IS (KJ/m2)
0 83.6 ± 9.9 11.0 ± 1.9 144.1 ± 5.8 6.5 ± 1.0 8.0 ± 1.9
250 57.1 ± 2.6 8.7 ± 1.2 87.1 ± 5.7 3.2 ± 0.3 36.5 ± 3.1
500 50.0 ± 2.1 8.1 ± 1.1 82.1 ± 5.0 3.0 ± 0.3 42.5 ± 3.2
750 49.9 ± 1.8 7.3 ± 0.7 73.2 ± 6.0 2.6 ± 0.4 51.6 ± 3.1
1000 34.2 ± 1.5 5.0 ± 0.3 44.3 ± 4.8 2.4 ± 0.5 34.1 ± 3.2
(TS)-Tensile strength, (YM)-Young's modulus, (FS)-Flexural strength, (FM)- Flexural modulus, (IS)-Impact strength, (KIc)-Fracture toughness, and (N.T.)- not tested.
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atures (i.e. below the PLA Tm) for more than 500 h. By comparing
aging in air and in water at 70 °C, the authors concluded that the hydro-
lysis aging can be neglected in air. At temperatures higher than 100 °C in
air, aging mechanism is undoubtedly oxidation. They also concluded
that the thermal oxidation mechanism of PLA at low temperatures
(T b 160 °C) leads to a random chain scission process, responsible for
the decrease of the PLA Mw as found by SEC measurements. Oxidation
affects the physical andmechanical properties of the polymer. These re-
sults come in agreement with some common behaviors observed dur-
ing polyoleﬁn oxidative aging. Consequently, knowing the chain
scission kinetics, it will be possible to predict the embrittlement time,
in other words the time when Mn is below 40 kg/mol: this time is
around 150 h, 250 h and 500 h for the PLA aged at 150, 130 and
100 °C respectively [220].
4. PLA properties improvement
4.1. Plasticizer and polymer blending
PLA is characterized by excellent optical properties and high tensile
strength but unfortunately, it is rigid and brittle at room temperature
(RT) due to its Tg ~ 55 °C [138]. Potentially, PLA fulﬁlls the packaging
industry's requirements for most of the rigid objects but the polymerFig. 9. (A)Visual change during aging of AUL and AAL composites. (B) SEM image of neat PLA sur
(Adapted from [216]).
Please cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10needs to be plasticized to be used as soft ﬁlms [155]. Indeed, developing
packaging materials requires high ﬂexibility at RT and thus, there is no
tolerance for the polymer ﬁlm tearing or cracking when subjected to
stresses during package manufacturing or use [138,221]. Other require-
ments which include transparency, low crystallinity and desired barrier
properties are also relevant for these applications [155]. To improve the
ductility of PLA-based materials, a large number of investigations have
been made to modify PLA properties via plasticization or polymer
blending (see Section 3.3/Table 10).
Plasticizers are widely used to improve processability, ﬂexibility and
ductility of polymers. In the case of semicrystalline polymers like PLA, an
efﬁcient plasticizer has to reduce the Tg but also to depress the Tm and
the crystallinity [155,222]. Lactidemonomer, for instance, is a good can-
didate to plasticizing PLAbut it tends tomigrate to thematerial's surface
causing a stiffening of the ﬁlms in time [155]. Rather than lactide, many
kinds of ester-like plasticizers for PLA have been studied such as glycer-
ol, sorbitol, bishydroxymethyl malonate (DBM) [223], glucose
monoesters and partial fatty acid esters, and citrates [79]. However,
the low Mw plasticizers have the problem of migrating, owing to
their high mobility within the PLA matrix. Therefore, plasticizers
with rather high Mw and low mobility are necessary. At least ﬁve
kinds of plasticizers with high Mw and being miscible to PLA without
any compatibilizer have been reported so far, i.e. PEG [79,224,225],
poly(propylene glycol) (PPG) [226], atactic poly(3-hydroxybutyrate)face afterweathering for 750 h, surface cracks aremarkedwith red arrows, scale bar 30 μm.
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Table 13
Mechanical properties of PLLA before and after accelerated hygrothermal aging [219].
T (°C) Young's modulus
(MPa) at t = 0
Young's modulus (MPa)
at t = 3 months
Evolution of
properties (%)
20 3655 ± 87 3682 ± 113 +1
40 – 3316 ± 216 −9
T (°C) Stress max (MPa)
at t = 0
Stress max (MPa)
at t = 3 months
Evolution of
properties (%)
20 60.5 ± 0.9 46.6 ± 0.1 −23
40 – 41.9 ± 3.7 −31
T (°C) Strain at break (%)
at t = 0
Strain at break (%) at
t = 3 months
Evolution of
properties (%)
20 2.5 ± 0.4 10.8 ± 1.2 +335
40 – 1.3 ± 0.4 −48
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[228], tributyl citrate-oligoester (TbC-oligoesters), diethyl
bishydroxymethyl malonate oligoester (DBM-oligoester) and
oligoesteramide (DBM-oligoesteramide) [223,229,230]. Despite the
wide diversity, the choice of plasticizer used as amodiﬁer for PLA is lim-
ited by the legislative or technical requirements of the application, and
in this context, its selection becomes more difﬁcult [223,230,231]. In
fact, the plasticizer used for PLA has to be biodegradable, non-toxic
for food contact (for food packaging applications) and/or biocompat-
ible (for biomedical applications). So far the most common plasti-
cizers used for PLA are low MW PEG [79,188,222,224,225,232,233],
citrate [175,229,230,234] and oligomeric lactic acid, giving the best
results, while glycerol was found to be the least efﬁcient plasticizer
[15,235,236].
Typically, 10–20%w/wamount of plasticizers are required to provide
both a substantial reduction of Tg of PLA matrix and adequate mechani-
cal properties. Regarding sustainability, the preferred plasticizer for PLA
should be biodegradable/bioresorbable, sufﬁciently non-volatile, and
with a relatively low Mw to produce the desired decrease of Young's
modulus value and increase of the impact strength. Moreover, the addi-
tion of more than 20–30% (depending on the plasticizer) of plasticizers
into PLA matrix leads to a phase separation which needs to be avoided.
The plasticization is thus limited by the amount of plasticizer to be
blended with PLA [231].
Grohens and coworkers reported a comprehensive study aimed tode-
termine thermal and mechanical properties of PLA (Mw 74,000 g/mol)
with PEG and several other oligomeric plasticizers (Fig. 10) that can be
used in food packaging [155]. The authors discussed the thermo-
mechanical PLA performances assessed for blends containing 10, 20,Fig. 10. Chemical structures of plasticizers that have
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crystallization temperature of pure components and blends with PLA
are given in Tables 14 and 15. The study outcome was that plasticizers
blended with PLA lowered the Tg and modiﬁed the melting and crystalli-
zation characteristics. The PEGs are themost efﬁcient plasticizers used for
PLA for the Tg reduction and it clearly appears that for compositions
higher than 20% of plasticizer, all the blends presented a limit of miscibil-
ity and the Tg reaches a plateau value. Results of static tensile experiments
are summarized in Fig. 11. It was found that the mechanical characteris-
tics of these materials showed a decrease in modulus and stress at break.
Nevertheless, the PLA blended to PEGs becomes very brittle as a function
of plasticizer content and Mw. The more efﬁcient plasticizers are PBOH,
AGM and DBS that give mechanical characteristics that can be consistent
with soft packaging applications [155].
Recently, David and coworkers have reported in situ reactive
grafting of hydroxy-terminated PEG plasticizer onto the maleic anhy-
dride modiﬁed PLA in PLA/PEG blends [231]. The authors declared that
grafting did not lead to a dramatic drop of PLAMwby thermal degrada-
tion or hydrolysis of ester chains while lowering signiﬁcantly the Tg
compared to the blends without grafting (neat PLA+ PEG) and a negli-
gible effect on viscoelastic and viscoplastic mechanical behaviors of PLA
was found.
Another study done by Sun and coworkers investigated the effects of
the plasticizer 1,2-cyclohexane dicarboxylic acid diisononyl ester
(Hexamoll® DINCH) on the thermal stability and degradation of PLA
and compared with tributyl citrate (TBC) and montmorillonite (MMT)
[235]. The authors found that the addition of Hexamoll® DINCH, TBC,
andMMT can efﬁciently decrease the Tg of PLA and improve the crystal-
linity of PLA polymer.
Although, huge attempts to improve PLA physical–mechanical prop-
erties for packaging ormedical applications using plasticizers have been
reported, there is limited information found regarding aging under sev-
eral conditions for these blends. Assessment of the property enhance-
ment on the stability of the plasticized material and the prevention/
limitation of the plasticizer migrating from the bulk is crucial for
intended material usage and should be further studied in the future.
4.2. Nucleation agents
The presence of additives in a pristine polymer resin can inﬂuence
the crystalline morphology and kinetics, so it can be used as a tool for
controlling/designing speciﬁc physical and mechanical properties by
providing nucleation sites for crystallization to initiate. Nucleating
agents can be chemical or physical in nature. So far several studies
have reported a variety of physical nucleating agents for PLA, including
talc and nanoclays [127,144,179,237–247]. Talc is often chosen due tobeen studied by Grohens and coworkers [155].
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Table 14
Tg of pure components and of blends between PLA and plasticizers.
[155].
Components Tg (°C) of PLA blends
100% 10% 20% 30%
Tg1 Tg2 Tg1 Tg2 Tg1 Tg2
Neat PLA 59.2 – – – – – –
PEG 200 −81.8 35.8 N.T. – – – –
PEG 400 −65.7 37.1 N.T. 18.6 −50.2 – –
PEG 1000 −81.0 40.2 N.T. 22.4 −62.7 29.9 −68.9
PBOH −64.7 47.6 N.T. 30.1 −48.5 29.4 −45.0
AGM −82.0 45.8 N.T. 24.3 −65.8 12.9 −56.9
DBS −81.7 39.9 N.T. 26.1 −66.9 29.2 −56.5
Tg1 corresponds to the PLA rich phase and Tg2 corresponds to the plasticizer rich phase.
N.T., not tested.
16 S. Farah et al. / Advanced Drug Delivery Reviews xxx (2016) xxx–xxxboth its low cost as well as its additional reinforcement effect. Angela
and Ellen have studied the relationship between crystallinity level and
mechanical performance in injection molded specimens of PLA [248].
They have used talc and ethylene bis-stearamide (EBS) as physical nu-
cleating agents, and they have done isothermal and nonisothermal crys-
tallization experiments and evaluated the ﬁnal crystalline content.
Mechanical performancewas assessed through ﬂexural and heat distor-
tion measurements. The study outcome showed for the ﬁrst time that
an increase in the crystallinity through an optimized injection molding
process and the addition of nucleating agents can result in a direct and
signiﬁcant improvement in mechanical performance of a commercial
grade of PLA [248]. The overall crystallization rate and ﬁnal crystallinity
of PLA were controlled by the addition of physical nucleating agents as
well as optimization of injection molding processing conditions. Talc
and ethylene bis-stearamide (EBS) nucleating agents both showed dra-
matic increases in crystallization rate and ﬁnal crystalline content as in-
dicated by isothermal and nonisothermal crystallization measurements
(Table 16), [248]. Isothermal crystallization halftimeswere found to de-
crease nearly 65-fold by the addition of just 2% talc. Process changes also
had a signiﬁcant effect on the ﬁnal crystallinity of molded neat PLA,
which was shown to increase from 5 to 42%. The combination of nucle-
ating agents and process optimization not only resulted in an increase in
ﬁnal injection molded crystallinity level, but also allowed for decreased
cycle processing times and reduced energy requirements in the injec-
tion molding process. The authors also reported signiﬁcant improve-
ments in mechanical performance of PLA, achieved by increasing the
overallmaterial crystallinity. An increase of over 30 °C in theheat distor-
tion temperature and improved strength and modulus by upwards of
25% were achieved. Thematerials with higher crystallinity showed cor-
respondingly increased mechanical properties and are thought to have
improved durability and degradability as well.
Other studies have reported the self-nucleation of PLA by adding
small crystallites of the stereocomplex which were formed from blend-
ing up to 15% PDLA into PLLA [237,249]. In comparison of self-
nucleation with the heterogeneous nucleation obtained from theTable 15
Melting and crystallization temperatures and enthalpies of pure components for PLA in PLA/pl
[155].
%Plasticizer 100% 10%
Tm (°C) ΔHm (J/g) Tc (°C) Tm (°C) ΔHm (J/g) Tc (
Neat PLA 154 0.5 – –
PEG 200 – – a 148.0 34.1 90.
PEG 400 6.9 113.0 a 150.8 32.4 102
PEG 1000 39.8 149.4 a 153.0 32.1 110
PBOH −15.5 1.8 −26.1 152.5 1.3 128
AGM −8.3 71.9 a 150.3 1.6 126
DBS −6.9 160.8 a 148.8 2.2 122
PLA melting enthalpies are normalized by the PLA content in the blends.
a Only classical crystallizations are observed for pure plasticizers.
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duced the crystallization half time by nearly 40-fold, in the best case,
while a similar loading of talc only decreased the half time by just
over 2-fold.
5. PLA's properties functions in applications
This part summarizes the applications of PLA and deeply discusses
the connection between the mechanical/physical properties of PLA
and the required features for medical and non-medical applications, as
well as pointing out current challengeswhichneed further investigation
for PLA performance improvement.
5.1. Medical application
PLA offers unique features of biodegradability, biocompatibility,
thermoplastic processability and eco-friendliness that offer potential
and being a bioresorbable polymer that play an increasingly important
role in biomedical applications due to their unique ability to be
completely resorbed in pre-designed time frames ranging frommonths
to a few years [162]. Furthermore, the ability to tailor their mechanical,
microstructural, chemical, and degradation properties for speciﬁc appli-
cations has catalyzed an extensive and growing amount of research
aimed at utilizing these materials in innovative ways and applications
[250]. PLA is used in a wide range of biomedical applications such as
stents [250–253], surgical sutures [254], plates and screws for
craniomaxillofacial bone ﬁxation [255], interference screws in ankle,
knee, and hand; tacks and pins for ligament attachment, anchors
[256], spinal cages [250,257], soft-tissue implants, tissue engineering
scaffolds, tissue cultures, drug delivery devices [258], and craniofacial
augmentations in plastic surgery [259]. In all of these applications, lactic
acid based polymers are exposed to different devices with speciﬁc load
environments. Each of these applications demands materials with spe-
ciﬁc physical, chemical, biological, biomechanical and degradation
properties to provide efﬁcient therapy [1]. The diversiﬁcation of PLA ap-
plications is such that a single polymermay prove useful inmany appli-
cations by simple modiﬁcations of its physical–chemical structure. In
many cases the PLA can be blended or copolymerized with other poly-
meric or non-polymeric components to achieve the desired behavior
[16,40].
The general criterion for selecting a polymer for use as a biomaterial
is tomatch themechanical properties and the timeof degradation to the
needs of the application. The mechanical properties match the applica-
tion so that sufﬁcient strength remains until the surrounding tissue has
healed. The selection starts by planning crystallinity level as it inﬂu-
ences many polymer properties including hardness, modulus, tensile
strength, stiffness, crease point, and melting point [3]. For example, in
applications where an implant will be under substantial load the family
of semicrystalline biodegradable polymers would typically be chosen
[62].asticizers blends.
20% 30%
°C) Tm (°C) ΔHm (J/g) Tc (°C) Tm (°C) ΔHm (J/g) Tc (°C)
– – – –
6 – – – – –
.2 18.6 −50.2 61.8 – –
22.4 −62.7 87.4 149.3 41.3
.5 30.1 −48.5 110.4 151.0 34.3 98.2
24.3 −65.8 99.3 143.4 31.4 67.8
.5 26.1 −66.9 78.2 143.4 32.0 85.4
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Fig. 11. (A) Tensile modulus (MPa) of pure PLA and plasticized PLA, (B) strain at break (%) of pure PLA and plasticized PLA, (C) stress at break (MPa) of pure PLA and plasticized PLA.
17S. Farah et al. / Advanced Drug Delivery Reviews xxx (2016) xxx–xxxFor a medical product, physical properties are important as well
where the designer should consider product dimensions, size, and
weight requirements. For example, to be light enough so a surgeon
can handle precisely while the design shouldmaintain the loads, stress-
es, and impact that the product might be face with during its use [4].
Other physical properties can be important including transparency/
opacity, color (some items might use color to aid in identiﬁcation), es-
thetics, water absorption, lubricity, and wear resistance. Important me-
chanical properties are tensile strength, tensile elongation, tensile
modulus, impact resistance (all for toughness), and ﬂexural modulus.
Accordingly, usage conditions such as temperature, chemical contactPlease cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10and resistance, and applied stresses during use, are considered where
PLAmechanical and physical properties can be tailored for use in a vari-
ety of processes and applications [8]. For example in tissue engineering,
the biostability of many scaffolds depends on the factors such as
strength, elasticity, and absorption at the material interface and its
chemical degradation [260]. The scaffold should have proper mechani-
cal properties and degradation ratewith thebioactive surface to encour-
age the rapid regeneration of the tissue. It is highly essential to retain
the mechanical strength of the scaffold structure after implantation for
the reconstruction of hard, load bearing tissues such as bone and carti-
lage [261]. To beused successfully, it is critical that a biomaterial scaffoldperties of PLA, and their functions in widespread applications — A
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Table 16
Effects of nucleating agents on thermal properties of injection molded PLA.
[248].
Samples Additive weight (%) Tga (°C) Tc1a (°C) Tma (°C) Tc2b (°C) Xca (%)
Neat PLA 0 64.3 115.9 172.4 n/a 10.0
PLA + EBS 2 63.6 93.2 169.4 97.4 18.5
PLA + talc 2 64.8 99.6 172.1 106.9 17.9
PLA + talc 5 62.7 95.2 171.5 110.9 15.4
PLA + talc 10 63.4 95.2 171.5 111.1 12.3
PLA + talc 20 60.8 92.9 171.6 112.6 20.8
Samples molded at room temperature.
a DSC program: heat at 10 °C/min to 220 °C.
b DSC program: heat at 10 °C/min to 220 °C, hold for 20min, cool at 10 °C/min to 25 °C.
Tc2 was determined from the ﬁnal cooling ramp.
18 S. Farah et al. / Advanced Drug Delivery Reviews xxx (2016) xxx–xxxtemporarily withstands and conducts the loads and stresses that the
new tissue will ultimately bear. Therefore, it is important to evaluate
one or more of the following rheological parameters: (i) elastic modu-
lus: measured strain in response to a given tensile or compressive stress
along the force; (ii) ﬂexural modulus: measured the relationship be-
tween a bending stress and the resulting strain in response to a given
tensile or compressive stress perpendicular under load; (iii) tensile
strength: maximum stress that the material can withstand before it
breaks; and (iv) maximum strain: ductility of a material or total strain
exhibited prior to fracture.
The mechanical properties and structural integrity of bulk biomate-
rials are altered by their processing into scaffolds of various pore sizes
and volume, shape, orientations and connectivity, and further that
these properties will rapidly diminish as a function of implantation
time [262]. It is critically important to understand these behaviors and
how they inﬂuence the material response in order to properly design
a medical device, and to analyze the device response under realistic
in vivo conditions.
Mechanical properties and degradation: The degradation behavior
of PLA is a critical characteristic of the material and the most important
reason for the high interest in its use inmedical applications. The stereo-
chemistry, crystallinity, Mw, and applied loads are the main factors
inﬂuencing the rate of degradation of PLA [163,263]. It has recently
been shown that the rate of degradation is also dependent on the mag-
nitude of the applied stress [165]. During degradation the yield strain,
yield stress, and elongation to failure all decrease. These changes in
yield stress, yield strain and elongation at failure can have consequences
for deviceswhich are loadbearing throughout their degradation process
[162,264]. For example in stent application, although the artery isFig. 12. Young's modulus and engineering strain to failure for different PLA materials.
(Reprinted from [162]).
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viscoplastic ﬂow may cause uneven loading in the vessel which could
have a negative impact on a tissue which is highly sensitive to changes
in the mechanical environment.
PLLAs exhibit high tensile strength and low elongation and conse-
quently have high modulus that makes them more applicable than the
amorphous polymers for load-bearing applications such as in orthope-
dic ﬁxation and sutures. PDLLA is an amorphous polymer having a ran-
dom distribution of both isomeric forms of lactic acid and accordingly is
unable to arrange into an organized crystalline structure. This material
has lower tensile strength and higher elongation and much more
rapid degradation timemaking it more attractive as a drug delivery sys-
tem [62]. PLLA is about 37% crystalline with a Tm of 175–178 °C and a Tg
of 60–65 °C [265]. The degradation time of PLLA is much slower than
that of PDLLA requiring greater than 2 years to be completely absorbed
[35]. Copolymers of L-lactidewith PCL, glycolide or DL-lactide have been
prepared to disrupt the L-lactide crystallinity accelerating the degrada-
tion process or include plasticizers to increase the ductility [266]. Fig. 12
summarizes the correlation between Young's modulus and elongation
to failure at RT for large intervals of PLA materials with the aforemen-
tioned microstructural states [162].
The following section details the required PLA properties and chal-
lenges to ﬁt potential applications in the medical industry.
5.1.1. Wound management and stent applications
PLA and its copolymerswere used in awide range of applications re-
lated to wound management, such as surgical sutures [254], healing
dental extraction wounds, and preventing postoperative adhesions.
For sutures it has recently been shown that the rate of degradation of
PLA is dependent on the magnitude of the applied stress [165,254]. An
additional complication is that PLA can exhibit premature failure at
stress magnitudes that are signiﬁcantly lower than both the yield
strength and the ultimate tensile strength of the material due to
viscoplastic ﬂow causing creep rupture or fatigue failure. As a result, in
some applications device failure can occur long before the material is
expected to fail due to degradation in vivo [162,264]. Another example,
a bioresorbable PLA stent, is exposed to very large stresses and strains
during the crimp and expansion steps. After deployment the stent typ-
ically contains large viscoplastic residual strains. Additionally it needs to
maintain its mechanical integrity when exposed to a large number of
load cycleswith low stress and strain amplitudes. The use of degradable,
non-linear, viscoplastic materials presents many new challenges to the
development and use of bioresorbable stents by altering themechanical
response of the devices to their in vivo environments. Accordingly, the
most commonly used material for bioresorbable scaffolds/stents is
PLLA [267,268]. However, due to the lower stiffness and strength of
PLLA compared to metals, the struts are typically required to be thicker
than what is used with conventional metal stents in order to obtain the
desired radial strength. This may lead to poor deliverability, platelet de-
position, and vessel injury [250–253,162]. In order to address these
challenges it is necessary to fully understand the mechanical response
of PLA implant/device. This requires in-depth characterization of
how the strength and stiffness of the material change due to time-
dependent microstructural mechanisms, how the material response
changes during degradation, and how the material undergoes non-
linear viscoplastic deformations at ﬁnite deformations. Similar to stents,
other applications require a longer retention of strength, such as liga-
ment and tendon reconstruction as well as urological surgery, where
PLLA ﬁbers are the preferred material as well [1,269].
5.1.2. Drug delivery system-based PLA
PLAs have been utilized for continuous drug release for different pe-
riods of time including prolonged administration of a wide variety of
medical agents such as contraceptives, narcotic antagonists, local anes-
thetics, vaccines, peptides and proteins [270,271]. Polymeric drug re-
lease can occur in one of three ways: erosion, diffusion and swelling.perties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
Table 17
List of commercial biodegradable devices.
[62,289].
Application Trade name Composition Manufacturer
Fracture ﬁxation SmartPins SR-PLLA Bionx Implants
SR-PGA
SmartScrew SR-PLLA
SmartTack
Phantom SofThread
Soft
Tissue Fixation Screw
PLLA DePuy
Orthosorb Pin PDO J & J
Orthopedics
Interference
screws
Full Thread Bio-
Interference Screw
PLLA Arthrex
Sheathed Bio-
Interference Screw
Phantom Interference
Screw
DuPuy
Biologically Quiet
Interference Screw
85/15
PDLLGA
Instrument Makar
BioScrew PLLA Linvatec
Sysorb Sulzer Orthopedics
Endo-Fix Screw PGA-TMC Smith and
Nephew
Suture anchors Bankart Tack SR-PLLA Bionx Implants
SmartAnchor-D
SmartAnchor-L
Phantom Suture
Anchor
PLLA DuPuy
BioROC EZ 2.8 mm Innovasive
DevicesBioROC EZ 3.5 mm
Biologically Quiet
Biosphere
85/15
PDLLGA
Instrument Makar
Biologically Quiet
Mini-Screw
Bio-Anchor PLLA Linvatec
GLS Mitek Products
Panalok
Panalok RC
Suretak 6.0 PGA-TMC Smith and
NephewSuretak 8.0
Suretak II w spikes
TAG 3.7 mmWedge
TAG Rod II
SD sorb 2 mm 82/18 PLLGA Surgical Dynamics
SD sorb 3 mm
SD sorb E-Z TAC
Bio-Statak PLLA Zimmer
Meniscus repair Menicus Arrow SR-PLLA Bionx Implants
Clearﬁx Meniscal Dart PLLA Innovasive
DevicesClearﬁx Meniscal Screw
Meniscal Stinger Linvatec
SD sorb Meniscal Staple 82/18 PLLGA Surgical Dynamics
ACL reconstruction Biologically Quiet
Staple
85/15
PDLLGA
Instrument Makar
Craniomaxillofacial
ﬁxation
LactoSorb Screws
and Plates
82/18 PLLGA Biomet
19S. Farah et al. / Advanced Drug Delivery Reviews xxx (2016) xxx–xxxFor PLA, the breakage of ester bonds occurred randomly through hydro-
lytic ester cleavage, leading to subsequent erosion of the device. The hy-
drolytic products from such degradation process are then transformed
into non-toxic subproducts that are eliminated through normal cellular
activity and urine [6]. PLA and their copolymers in the form of micro or
nano-particles were used in the encapsulation process of many drugs,
such as psychotic [272], restenosis [273], hormones [274], oridonin
[275], dermatotherapy [276], and protein (BSA) [277]. PLA particles
were prepared using solvent evaporation technology and found ideal
candidates for the design of drug delivery systems. It has been found
that the challenge of controlled drug release can be tuned bymechanical
stability and crystallinity degree of PLA in the formulation [44].
5.1.3. Orthopedic and ﬁxation devices
The challenges associated with PLA usage for orthopedics are highly
dependent on the location and type of device intended to be used [162].
While typical devices are composed of steel or titanium to ensure that
the devices are capable of withstanding in vivo loading over long pe-
riods of time [278], polymers have advantages over metal implants in
that they transfer stress over time to the damaged area, allowing
healing of the tissues [62]. Another important advantage is avoiding a
second surgical procedure to remove unnecessary hardware, which re-
duces medical costs and allows for the gradual recovery of tissue func-
tion as the device is degraded simply by hydrolysis without any use of
enzymes or catalysts (Fig. 13) [1,44,279]. Historically, the PLA polymer
was used to produce biodegradable screws and ﬁxation pins, plates,
and suture anchors. These types of absorbable screws and pins have
been gaining widespread clinical use, particularly in cases where high
mechanical stiffness or strength was not required. Pertinent orthopedic
areas might include the knee [280–282], shoulder, foot and ankle [283,
284], hand, wrist [285], elbow [286], pelvis, and zygomatic fractures. In
some other cases, high performance PLA is needed and it was found
quite challenging to achieve. Haers et al. [279] reported an improve-
ment of the mechanical properties of PLA through the control of the
L/D ratio in the polymer, where the ratio of L/D 85/15was polymerized,
and the prepared PLAwas used for themanufacture of screws and ﬁxa-
tion plates used in fracture ﬁxation. The results showed that it was pos-
sible to use the plates without the need for additional support for the
ﬁxation of fractures (Fig. 13). These degradable devices in comparison
to their metallic counterparts were found to exhibit similar rates of suc-
cess [8,287,288]. However, in these applications it is important that the
applied stress never gets so large that the implant undergoes signiﬁcant
permanent deformation, or premature failure due to viscoplastic ﬂowor
fracture [162].
Since materials for bone ﬁxation require high strength, close to that
of bone, PLLA has a large application in this ﬁeld. In Barber's review, 22
of the listed 40 orthopedic devices were composed of PLLA (Table 17)
[62,289]. Another application of PLLA in the form of injectable micro-
spheres for temporary ﬁllings in facial reconstructive surgery has also
been reported [6].Fig. 13. (a) Screws and plate made of PLA (b) upper jawwith the plates and screws in situ (c) and (d) lateral cephalogram, with the screws and plate, taken immediately postoperatively
and 6 weeks postoperatively, respectively.
(Adapted from [44,279]).
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Tissue engineering is one of the most exciting interdisciplinary and
multidisciplinary research areas where PLA usage has grown exponen-
tially over time. Scaffold materials and fabrication technologies play a
crucial role in tissue engineering and regeneration [260]. PLA matrix
materials have found enormous interest as supports because of the
fact that the support disappears from the transplantation site with the
passage of time, leaving behind a perfect patch of the natural neo-
tissue [1,16]. PLA has been investigated for tissue engineering applica-
tions, such as bone scaffolds, because of the good biocompatibility of
this polymer [290]. However different tissue nature requires relative
material strength with a pre-planned biodegradation proﬁle. The me-
chanical properties of PLAwere reported to be improved for tissue engi-
neering using a range ofmethods, such as blending, composites forming
(i.e. [291]), and co-polymerization [44]. Three dimensional porous scaf-
folds of PLA have been created for culturing different cell types, using in
cell based gene therapy for cardiovascular diseases; muscle tissues,
bone and cartilage regeneration and other treatments of cardiovascular,
neurological, and orthopedic conditions [292–294]. Another two studies
have reported osteogenic stem cells seeded on scaffolds of this material
and implanted in bonedefects or subcutaneously for recapitulating both
developmental processes of bone formation: endochondral ossiﬁcation
and intramembranous ossiﬁcation [295,296]. Due to the high strength
of PLLA mesh, it is possible to create 3D structures such as trays and
cages [297]. The PLAmay take 10months to 4 years to degrade, depend-
ing on the microstructural factors such as chemical composition, poros-
ity and crystallinity that may inﬂuence tensile strength for speciﬁc uses
[1]. Moreover, lactic polymers can stimulate isolated cells to regenerate
tissues and release drugs such as painkillers, anti-inﬂammatories and
antibiotics, which have recently motivated their study as scaffolds for
cell transplantation [6,298,299].
PLA scaffold degradation — scaffolds should maintain their me-
chanical properties until it is no longer needed. In consecutive
order, the scaffold degraded, absorbed, and excreted by the body,
leaving no trace [62]. Scaffolds gradually degrade by predetermined
periods to be replaced by newly grown tissue from the adhered cells
[300]. Degradation results in scaffold dismantling and material dis-
solution/resorption through the scaffold bulk and/or surface types
of degradation [62,260]. The biodegradation rate of a biopolymer
depends mainly on its intrinsic properties, including, chemical
structure, the presence of hydrolytically unstable bonds, level of hy-
drophilicity/hydrophobicity, crystalline/amorphous morphology,
Tg, copolymer ratio, and its Mw [301]. Other interrelated factors
should be taken into account for predicting the mechanism of
bioerosion, including a) the presence of catalysts, additives, impuri-
ties or plasticizers, b) the geometry of the device and c) the location
of the device. Also implants under stress have been reported to de-
grade faster. A potential explanation to this phenomena have pro-
posed that in stressed implant a microcracks may form, leading to
an increase in the exposed surface area to water [164,165]. For sum-
mary, balancing all of these factors to tailor an implant for slow deg-
radation and transfer stress to the surrounding tissue as it heals at
the appropriate rate are the keys for biomedical device success.
PLA and 3D printing—Merging the 3D printing technology with in-
trinsic properties of PLA was found to be a promising way to produce
complex biomedical devices according to computer design using
patient-speciﬁc anatomical data as well as in wide range of industrial
and architectural applications [302]. Speciﬁcally, in biomedical applica-
tion, PLA 3Dprinting has slowly evolved to create one-of-a-kind devices
and also improvement in implants and scaffold performance for tissue
engineering, diagnostic platforms, and drug delivery systems [303].
PLA printing was found feasible for the aforementioned applications
mainly by using direct or indirect 3D printing and fused deposition
modeling technologies. Helena and Benjamin have reported an excel-
lent summary on the recent progress in PLA 3D printing technologies
for tissue engineering [303].Please cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10Fueledwith the recent advances in cell manipulation technology and
nano-machinery it can be anticipated that the interest in combining
stem cells with custom PLA 3D scaffolds for personalized regenerative
medicine is the growing spot of PLA 3D printing. However, before PLA
3Dprinting can be used routinely for the regeneration of complex tissues
(e.g. bone, cartilage, muscles, vessels, nerves in the craniomaxillofacial
complex), and complex organs with intricate 3D microarchitecture
(e.g. liver, lymphoid organs), several technological limitations and
balancing between physical/mechanical properties and biodegradation
must be addressed. Deep understanding of these limitations should mo-
tivate future research and advance this fascinating ﬁeld for advanced
manufacturing.
5.1.5. Other applications
Other applications for PLA and its copolymers have been reported
[304,305]. These studies have reported for the ﬁrst time the use of lactic
acid based polymers for fabrication of implantable biodegradable inﬂat-
able balloons. These balloons were designed for reducing radiation ad-
verse effects in prostate cancer by prostate–rectum separation (up to
9mm) or as a sub-acromial spacer in the treatment of massive irrepara-
ble rotator cuff tears (Fig. 14) [304–306]. Balloon's shape, mechanical
and chemical properties were premeditated to withstand the different
surrounding tissue stress following minimally invasive balloon deploy-
ment and in situ inﬂation, up to a desired period of time (weeks–
months) and then gradually biodegrade. For these applications, they
have controlled the balloon mechanical stability by its wall thickness
andMw. The balloon's safety and efﬁcacywas established in amamma-
lianmodel and they havemaintained their performance along the study
followed by biodegradation without toxicity [304,305]. Recently, clini-
cal studies have evaluated the safety and efﬁcacy of these balloons for
long term performance (up to 3 years of post-implantation) and the re-
sults were found promising, no safety issues were raised [306–308].
This example represents a good model for PLA property optimization
and device fabrication to fulﬁll medical need, starting with proper poly-
mer composition, implant degradability–mechanical stability balancing
and proper sterilization technique development.
5.2. Non- medical application
Globally, bioplastics make up nearly 300,000metric tons of the plas-
tic market. Even though it sounds like a lot, this only accounts for less
than 1% of the 181 million metric tons of synthetic plastics the world
produces each year. Nevertheless, the bioplastic market is growing by
20–30% each year [160]. As we proceed forward into the 21st century,
an increased utilization of renewable resources will be one of the strong
drivers for sustainable products. Reduced energy consumption, waste
generation, and emission of greenhouse gases will take on greater em-
phasis. PLA is the ﬁrst commodity plastic to incorporate these principles
and is currently the most promising and popular material with the
brightest development prospect and is considered as the ‘green’ eco-
friendly material [8,160]. PLA is ideally suited for many applications in
the environment where recovery of the product is not practical, such
as agricultural mulch ﬁlms and bags. Composting of post-consumer
PLA items is also a viable solution formany PLA products. Biodegradable
plastics, packaging and paper coatings, sustained release systems for
pesticides and fertilizers and compost bags etc. are also examples of
PLA usage in non-medical application. However, the large growth seen
for PLA in many applications does not depend solely upon the biode-
gradability of the material. Each grade is optimized for both processing
and end use performance in its intended application.
Currently, Nature Works LLC is the leader in lactic polymer technol-
ogy andmarkets. Over the past 10 years, this company has done exten-
sive work on the development of lactic acid-based products, which are
of two types-the PLA-based resins (Nature-Works PLA) used for plastics
or packaging applications, and the Ingeo™ polydilactide-based ﬁbers
that are used in specialty textiles and ﬁber applications [160]. Fiberperties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
Fig. 14. (A) Prostatic lactic acid based balloon was preshaped to separate and retract prostate from nearby rectum to reduce radiation adverse effects in patients with prostate cancer
(adapted from [305]). (B) Schematic representation of lactic acid based balloon (ProSpace™) inﬂated with a physiological saline and sealed in situ in between the rectum wall and the
prostate gland spacing up to 9 mm between the two organs (adapted from [304]). (C) Schematic representation of lactic acid based balloon (InSpace™) deployment and inﬂation in
the sub-acromial space through an insertion tube.
(Adapted from [306]).
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PLA is readily melt spinnable, stress crystallizes upon drawing, and
can be designed for many ﬁber applications. Some of the current ﬁber
uses include hollow ﬁberﬁll for pillows and comforters, bulk continuous
ﬁlament for carpet, ﬁlament yarns, and spun yarns for apparel, spun
bond, and other nonwovens and bicomponent ﬁbers for binders and
self-crimping ﬁbers. In the form of non-woven textiles, PLA also has
many potential uses, for example as upholstery, disposable garments,
awnings, feminine hygiene products, and nappies. Most ﬁber applica-
tions require polymer with high optical purity (OP) to allow high levels
of crystallinity to develop and to have adequate heat resistance in the
application. Binder ﬁbers are unique in that low crystallinity in the
sheath layer is desired to allow ease of melting and adhesion to other
ﬁbers; thus, high (8–20%) D- or meso-lactide content is incorporated
[8]. PLA can be processed on standard thermoplastic ﬁber spinning
equipment with the appropriate temperature proﬁles relative to its
crystal melting point. Melt temperatures of 200–240 °C are typically
used. PLA is replacing PET in these applications because of its superior
performance and the fact that the disposable products can be produced
from ﬁbers that are from 100% renewable resources and fully biode-
gradable. Some of the beneﬁcial characteristics of PLA ﬁber products in-
clude its natural soft feel, ease of processing, and unique stain and soil
resistance. PLA excels at resistance to stain in standard tests with coffee,
cola, tea, catsup, lipstick, and mustard. PLA also burns with low smoke
generation, has good ultraviolet resistance, is easily dyeable, and brings
good wickability of moisture to applications [8].
Films are the second largest application area for PLA. Films are
transparent when stress crystallized and have acceptance by cus-
tomers for food contact. PLA ﬁlms also have superior dead fold or
twist retention for twist wrap packaging [8]. Different types of PLA
resins with different application ranges are being produced and
each customer should specify packaging demands and match them
with PLA data sheets. For example, PLA in food packaging applica-
tions is ideal for fresh products and those whose quality is not dam-
aged by PLA oxygen permeability [3]. PLA is a growing alternative as
a “green” food packaging polymer. New applications have been
claimed in the ﬁeld of fresh products, where thermoformed PLA con-
tainers are used in retail markets for fruits, vegetables, and salads.
For a few years, natural foods purveyors have been quietly using
some PLA products, but the material got its biggest boost when
Wal-Mart, the world's largest retailer, announced that they will sell
some produce in PLA containers [160]. That ﬁeld of application of
biodegradable polymer in food-contact articles includes also dispos-
able cutlery, drinking cups, salad cups, plates, overwrap and lamina-
tion ﬁlm, straws, stirrers, lids and cups, plates and containers for food
dispensed at delicatessen and fast-food establishments. These arti-
cles will be in contact with aqueous, acidic and fatty foods that are
dispensed or maintained at or below room temperature, or dis-
pensed at temperatures as high as 60 °C and then allowed to coolPlease cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10to RT or below. So accordingly PLA based polymer's optical, physical
and mechanical properties should be tailored [309]. The market ca-
pacity of these products packaged in PLA is unlimited. For today,
the major PLA application is in packaging (nearly 70%), while the es-
timation for 2020 shows the increase of other applications especially
in ﬁbers and fabrics (up to 50%) [3]. In this ﬁeld, as a native form or in
a blend, PLA contributes tremendously to packaging material stiff-
ness, clarity, deadfold and twist retention, low-temperature heat
sealability, and special barrier characteristics (i.e. aroma and ﬂavor).
The functional properties and beneﬁts of PLA in these areas are pre-
sented in Table 18 [3,310]. Although complete replacement of syn-
thetic packaging ﬁlms with eco-friendly packaging ﬁlms is still far
from full achievement, at least for speciﬁc applications like food
packaging the use of bioplastics should be the future.
PLA challenges for the non-medical application and modiﬁcations—
besides the main challenge of lowering the PLA manufacturing cost to
hit 1.0 US$/kg or lower, other major technical challenges to widespread
acceptance of bio-based polymers are difﬁculties achieving mechanical
and barrier properties comparable with conventional synthetic
polymers while maintaining biodegradability. Another challenge: PLA
inferior moisture barrier properties compared to synthetic polymers
[160]. So management of moisture penetration and hydrolytic degrada-
tion of PLA is extremely important during the manufacturing, shipping,
storage, and end-use of PLA products [311]. The inherent brittleness of
PLA has also been a major bottleneck for its large-scale commercial
applications.
To improve the barrier properties several approaches are available
(i.e. Table 10): i) use of coating with materials which would add hydro-
phobicity to the packaging material, ii) lamination of two or more
biopolymers (co-extrusion), iii) use of an edible coating with the re-
quired barrier properties for the food and subsequently use biopolymers
as primary packaging, iv) development of blends of biopolymers with
different properties, some examples include PLA/PEG blends, PLA/PHA
blends and PLA/PCL blends, v) chemical and/or physical modiﬁcation
of biopolymers, and vi) development of micro- and nanocomposites
based on biopolymers [170,312]. Co-extruded laminated ﬁlms are al-
readywidely used in food packaging applications. Themajor drawbacks
of thesemethods are the substantial decreases in the strength andmod-
ulus of the toughened PLA. So, a PLA based material having good stiff-
ness–toughness balance along with high biobased PLA content is still
elusive [160]. For example: ﬂexibility improvement was achieved by
plasticizing PLAwith its ownmonomers, PLA becomes increasingly ﬂex-
ible so that a continuous series of products can be prepared that can
mimic PVC, LDPE, LLDPE, PP, and PS. For food contact applications a
number of plasticizers or polymers have been reported [155], PLA
has been blended with polymers such as poly(hydroxybutyrate),
poly(vinylacetate), poly(ethylene oxide) and polysaccharides [189,
313,314]. However, these polymer blends generally exhibit phase sepa-
ration in the whole or part of the composition range similar toperties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
Table 18
PLA functional properties for packaging.
[3,310].
Functional property Packaging improvement Comment
Dead fold, twist, and crimpa Improved folding and sealing OPLA has excellent dead fold and twist retention
High gloss, and clarity Package esthetics Comparable with PET and cellophane, 3 times more than nylon
and PP, 10 times more than LDPE
Barrier properties Grease and oil resistance Good resistant to oils and terpenes
Renewable resource Made from CO2 and H2O
Flavor and aroma properties Reduced taste/odor issues
Low temperature heat seal Stronger seals at lower temperatures PLA can provide an “easy-open” package
High tensile and modulus Wet paper strength, ability to down gauge coating
Low coefﬁcient of friction, polarity Printability Excellent printability, metallizable, antifogging ability
GRAS status Food contact approved
a The ability to hold a crease or fold, or the ability to retain a twist that is imparted in order to close the edges of the ﬁlm around a small object.
Fig. 15. Schematic representation of PLA ﬁlm with nisin as an active agent incorporated
and release thereof.
(Reprinted from [3]).
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it is important to take into account that product shelf life is favored by
decreasing plasticizer content and/or orientation [160].
Another typical investigative approach is the use of nanometric
additives [315], which have been reported to dramatically change rheo-
logical properties of polymer melts and to improve functional proper-
ties such as barrier to gases and vapors, mechanical properties and
thermal stability, for example, nanocomposites of the aPLA and aPLA/
PCL blends were obtained bymelt-mixing with a properly modiﬁed ka-
olinite showed an improvement in these properties with regard to the
polymers and blends without clay [312]. It was found that PLA based
nanocomposites have exhibited higher rates of PLA biodegradation in
compost by the addition of nanoclays, which was attributed to the
high relative hydrophilicity of the clays, allowing an easier permeability
of water into the polymermatrix and activating the hydrolytic degrada-
tion process [316]. Zhou and Xanthos studied the size effect and the ki-
netics of the thermal degradation of PLAs and they have concluded that,
in general, the thermal stability of PDLLA and its composites is higher
than that of PLLA and its composites and the thermal stability of the
nanocomposites is higher than that of the microcomposites [215]. This
new generation of PLA-based nanocomposites exhibits signiﬁcant im-
provements in modulus, dimensional stability and solvent or gas resis-
tance with respect to the pristine polymer at very low ﬁller content
(0.5–5% w/w), also offer extra beneﬁts like low density, transparency,
good ﬂow, better surface properties and recyclability. Various inorganic
nano-particles have been recognized as possible additives to enhance
the polymer performance [171]. So with the help of nanotechnology
and providing safe PLA nanocomposites, many of its weakness com-
pared to petrochemical-based polymer will be resolved and increase
the application potential of PLA-based nanocomposites in food packag-
ing, besides medical applications, and tissue cultures [3]. Potentials and
problems associated with the use of nanoscaled ﬁllers to PLA have been
recently reviewed [115,171,315,317]. The research and development of
bio-nanocomposite materials for packaging applications is expected to
grow in the next years, due to the possibility of improving both packag-
ing performance and process technology of biopolymers.
For PLA's ﬁber performance improvement, itwas found that it can be
combined with natural or regenerated ﬁbers including cotton, wool,
silk, viscose, lyocell, and others along with synthetic ﬁbers made from
PET, nylon, and other petroleum-based synthetics [8].
PLA and active packaging applications — active packaging realizes
certain extraordinary and vital functions other than providing an inert
barrier between product and external conditions. Active substances
that are important and considered for novel bioactive packaging include
antimicrobials, vitamins, phytochemicals, prebiotics, marine oils, and
immobilized enzymes [318]. Speciﬁcally, antimicrobial packaging
trends have been widely reported. The innovative strength of PLA anti-
microbial packaging has a direct impact on consumer health by creating
safer and more wholesome packaged foods as well as prolong the shelf
life of packaged food products by slowing down or inhibiting thosePlease cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10mechanisms that are responsible for packaged food products unaccept-
ability [170]. A whole range of active additives, including silver-
substituted zeolite, organic acids and their salts, bacteriocins such as
nisin and pediocin, enzymes such as lysozyme, a chelator like ethylene-
diaminetetraacetic acid (EDTA), lactoferrin, and plant extracts have al-
ready been successfully incorporated in antimicrobial active packaging
[319]. Successful introduction of a new active packaging requires careful
attention to the interactions in the active agent, packaging, and food tri-
angle. Themostwidely used bacteriocin in active food packaging is nisin
due to its GRAS status [320]. Fig. 15 shows schematic representation of
PLA ﬁlm for food packaging with nisin as an active agent incorporated
and release strategy. The mechanical and physical properties of the
PLA are the key role for effective and preplanned release of nisin.perties of PLA, and their functions in widespread applications — A
.1016/j.addr.2016.06.012
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rial slows down their release and helps tomaintain high concentrations
of the active compounds against pathogenic bacteria like Listeria
monocytogenes [321]. In the last decade, the above-mentioned slow re-
lease approach has been used for PLA. In this regard, major antimicrobi-
al agents include bacteriocins, predominantly nisin [321], lactic acid
[322], lysozyme [323], and chitosan [324,325]. Solvent casting tech-
nique was extensively reported for starch, zein and PLA-based antimi-
crobial ﬁlm production [319,326–328]. However, the use of extrusion-
based processing, industrially employed for the manufacturing of pack-
aging ﬁlms, could affect the functionalities of antimicrobial compounds
embedded in the polymeric matrix [3].
Although the above-mentioned PLA systems reduced resistant bac-
terial strain development and guaranteed a higher level of microbial
protection for certain food products, their casting and preparation
were still complicated and challenging due to reported cases of process-
ing inactivation. Up until now, a literature study reveals that relatively
low attention has been given to micro-encapsulated active agents in
foods. Active agent-loaded polymeric micro-/nanoparticles give the im-
pression of being promising formulations to achieve long-lasting anti-
microbial activity as they will prevent the invasion of bacteria and
micro-organisms [329], and should be further focused on and it can be
enlarged to the applications of other active agents like antioxidants for
oil rich foods and antisticking/antifogging agents for cheese slices and
fresh fruits, respectively. Controlling and manipulation of physical and
mechanical properties of PLA (i.e. D/L ratio and Mw) is the key role for
long lasting successful active packaging.
6. Summary and outlook
PLA is a leading candidate for consumer andbiomedical applications,
and the ability to tailor its mechanical, physical, microstructural, chem-
ical, and degradation properties for speciﬁc applicationsmakes themar-
ket capacity of PLA products unlimited and that has catalyzed an
extensive and growing amount of research aimed at utilizing these ma-
terials in innovative ways and applications.
The intention of thiswork is to give an overview on state of the art of
the research activities on PLA's physical and mechanical properties, de-
tailing a wide range of options for properties improvement such as
chemical composition manipulation (D/L ratio), processing, additives
and plasticizers, and polymeric component blending. This review has
also covered the major concerns about PLA physical and mechanical
property variation during processing, recycling, biodegradation and
aging, as well as discussed the thermal instability impact on these prop-
erties. The last part of this review has provided an overview on PLA's
physical and mechanical properties' role and function in widespread
application.
Our vision for PLA's future comes in agreementwith the logical belief
that there is no one material able to satisfy all design parameters in
all applications. So, it can be anticipated that future developments will
keep including blends of PLA, copolymers, and impact-modiﬁed prod-
ucts, which will also further expand the applications where this unique
polymer can be used. Besides that, we do expect for the nearby future
increasing research interest in the following four areas:
a) PLA blends stability: recently, several PLA blends based synthetic or
natural components have been reported and found very efﬁcient in
PLA properties improvement [235,330–343]. However, very limited
attention have been given for studying blends stability under differ-
ent aging conditions (e.g. in different environments, during storage,
during reprocessing), this part is highly essential and should be fur-
ther focused on impartial evaluation of these new compositions ad-
vantage, in terms of durability and applicability, in comparison to
classical reported compositions (PLA:PGA, PLA:PCL, etc.).
b) PLA-based nanocomposites: the linkage of a 100% bio-originated
material and nanomaterials opened new windows for becomingPlease cite this article as: S. Farah, et al., Physical and mechanical pro
comprehensive review, Adv. Drug Deliv. Rev. (2016), http://dx.doi.org/10independent from petrochemical-based polymers and many of
PLA's weakness have been resolved [172,173]. This new generation
of PLA based nanocomposites was found to exhibits signiﬁcant im-
provements, at very low ﬁller contents (0.5–5% w/w), with the
help of nanotechnology and providing safe PLA nanocomposites.
The research and development of bio-nanocomposite materials for
packaging applications (especially for direct food contact packaging
materials) is expected to grow in the next years, due to the possibil-
ity of improving both packaging performances and process technol-
ogy of biopolymers. In this area, we have also found that less
attention has been given to inorganic nano-particles while various
have been recognized as possible additives to enhance the polymer
performance, their potential in combination with PLA should be
further studied.
c) Composites of ﬁber mixtures: such mixtures combine the positive
properties of different ﬁbers [334–343]. Learning from nature what
the function of aﬁber in a plant iswe candesign the composite prop-
erties by adding seed ﬁbers with high elongations for improved im-
pact or stem ﬁber for improved stiffness. The role of the reinforcing
ﬁber should be more focused in future research activities of PLA
composites. Playing with the different ﬁber characteristics a design
of composite properties is possible. The results have shown so far
that the investigated composites with their various characteristics
can be used for different technical applications, each suiting speciﬁc
requirements.
d) Computational modeling of PLA behavior for different applications:
the magnitude of experimentally observed nonlinear behaviors of
PLA's properties increases the importance of computational model-
ing to both understand how a device-based lactic acid will behave
in a given environment, and to optimize the device for a given appli-
cation. A number of carefully developed constitutivemodels are now
under development for predicting the material response in different
load environments (i.e. simulating PLLA stent ﬁxed inside artery).
These models, if applied properly, can provide great insight into
the response of variousmaterials and designs. Due to the high inter-
est in this area from both academia and industry, we can only expect
computationalmodeling to become evenmore powerful in the com-
ing years.
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